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Abstract
Background: The Proteomic Code is a set of rules by which information in genetic material is
transferred into the physico-chemical properties of amino acids. It determines how individual
amino acids interact with each other during folding and in specific protein-protein interactions. The
Proteomic Code is part of the redundant Genetic Code.
Review:  The 25-year-old history of this concept is reviewed from the first independent
suggestions by Biro and Mekler, through the works of Blalock, Root-Bernstein, Siemion, Miller and
others, followed by the discovery of a Common Periodic Table of Codons and Nucleic Acids in
2003 and culminating in the recent conceptualization of partial complementary coding of interacting
amino acids as well as the theory of the nucleic acid-assisted protein folding.
Methods and conclusions: A novel cloning method for the design and production of specific,
high-affinity-reacting proteins (SHARP) is presented. This method is based on the concept of
proteomic codes and is suitable for large-scale, industrial production of specifically interacting
peptides.
Background
Nucleic acids and proteins are the carriers of most (if not
all) biological information. This information is complex,
well organized in space and time. These two kinds of mac-
romolecules have polymer structures. Nucleic acids are
built from four nucleotides and proteins are built from 20
amino acids (as basic units). Both nucleic acids and pro-
teins can interact with each other and in many cases these
interactions are extremely strong (Kd ~ 10-9-10-12 M) and
extremely specific. The nature and origin of this specificity
is well understood in the case of nucleic acid-nucleic acid
(NA-NA) interactions (DNA-DNA, DNA-RNA, RNA-
RNA), as is the complementarity of the Watson-Crick (W-
C) base pairs. The specificity of NA-NA interactions is
undoubtedly determined at the basic unit level where the
individual bases have a prominent role.
Our most established view on the specificity of protein-
protein (P-P) interactions is completely different [1]. In
this case the amino acids in a particular protein together
establish a large 3D structure. This structure has protru-
sions and cavities, charged and uncharged areas, hydro-
phobic and hydrophilic patches on its surface, which
altogether form a complex 3D pattern of spatial and phys-
ico-chemical properties. Two proteins will specifically
interact with each other if their complex 3D patterns of
spatial and physico-chemical properties fit to each other
as a mold to its template or a key to its lock. In this way
the specificity of P-P interactions is determined at a level
higher than the single amino acid (Figure 1).
The nature of specific nucleic acid-protein (NA-P) interac-
tions is less understood. It is suggested that some groups
of bases together form 3D structures that fits to the 3D
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structure of a protein (in the case of single-stranded
nucleic acids). Alternatively, a double-stranded nucleic
acid provides a pattern of atoms in the grooves of the dou-
ble strands, which is in some way specifically recognized
by nucleo-proteins [2].
Regulatory proteins are known to recognize specific DNA
sequences directly through atomic contacts between pro-
tein and DNA, and/or indirectly through the conforma-
tional properties of the DNA.
There has been ongoing intellectual effort for the last 30
years to explain the nature of specific P-P interactions at
the residue unit (individual amino acid) level. This view
states that there are individual amino acids that preferen-
tially co-locate in specific P-P contacts and form amino
acid pairs that are physico-chemically more compatible
than any other amino acid pairs. These physico-chemi-
cally highly compatible amino acid pairs are complemen-
tary to each other, by analogy to W-C base pair
complementarity.
The comprehensive rules describing the origin and nature
of amino acid complementarity is called the Proteomic
Code.
The history of the Proteomic Code
People from the past
This is a very subjective selection of scientists for whom I
have great respect; I believe they contributed – in one way
or another – to the development of the Proteomic Code.
Linus Pauling is regarded as "the greatest chemist who
ever lived". The Nature of the Chemical bond is fundamental
to the understanding of any biological interaction [3]. His
works on protein structure are classics [4]. His uncon-
firmed DNA model, in contrast to the established model,
gives some theoretical ideas on how specific nucleic acid-
protein interactions might happen [5,6].
Carl R Woese is famous for defining the Archaea, the third
life form on Earth (in addition to bacteria and eucarya).
He also proposed the "RNA world" hypothesis. This the-
ory proposes that a world filled with RNA (ribonucleic
acid)-based life predates current DNA (deoxyribonucleic
acid)-based life. RNA, which can store information like
DNA and catalyze reactions like proteins (enzymes), may
have supported cellular or pre-cellular life. Some theories
about the origin of life present RNA-based catalysis and
information storage as the first step in the evolution of cel-
lular life.
Forms of peptide to peptide interactions Figure 1
Forms of peptide to peptide interactions. The specificity of interactions between two peptides might be explained in two ways. First, 
many amino acids collectively form larger configurations (protrusions and cavities, charge and hydropathy fields) which fit each other (A 
and D). Second, the physico-chemical properties (size, charge, hydropathy) of individual amino acids fit each other like "lock and key" (C 
and E). There are even intermediate forms (B).Theoretical Biology and Medical Modelling 2007, 4:45 http://www.tbiomed.com/content/4/1/45
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The RNA world is proposed to have evolved into the DNA
and protein world of today. DNA, through its greater
chemical stability, took over the role of data storage while
proteins, which are more flexible as catalysis through the
great variety of amino acids, became the specialized cata-
lytic molecules. The RNA world hypothesis suggests that
messenger RNA (mRNA), the intermediate in protein pro-
duction from a DNA sequence, is the evolutionary rem-
nant of the "RNA world" [7].
Woese's concept of a common origin of our nucleic acid
and protein "worlds" is entirely compatible with the foun-
dation of the Proteomic Code.
Margaret O Dayhoff is the mother of bioinformatics. She
was the first who collected and edited the Atlas of Protein
Sequence and Structure [8] and later introduced statistical
methods into protein sequence analyses. Her work was a
huge asset and inspiration to my first suggestion of the
Proteomic Code [9-11].
George Gamow was a theoretical physicist and cosmolo-
gist and spent only a few years in Cambridge, UK, but he
was there when the structure of DNA was discovered in
1953. He developed the first genetic code, which was not
only an elegant solution for the problem of information
transfer from DNA to proteins, but at the same time
explained how DNA might specifically interact with pro-
teins [12-17]. In his mind, the codons were mirror images
of the coded amino acids and they had very intimate rela-
tionships with each other. His genetic code proved to be
wrong and the nature of specific nucleic acid-protein
interactions is still not known, but he remains a strong
inspiration (Figure 2) [18,19].
First generation models for the Proteomic Code
The first generation models (up to 2006) of the novel Pro-
teomic Code are based on perfect codon complementarity
coding of interacting amino acid pairs.
Mekler
Mekler described an idea of sense and complementary
peptides that may be able to interact specifically, medi-
Biological information flow (transformation and recognition) between nucleic acids and proteins Figure 2
Biological information flow (transformation and recognition) between nucleic acids and proteins. All biological information is stored in 
nucleic acids (DNA/RNA) and much in proteins (P). The information transfer and interactions between nucleic acids and the formation of 
double-stranded (ds) forms are well known and understood. However, the exact nature of P-P and P-nucleic acid interactions is still 
obscure. The works of these four scientists played important roles in much that we know about such information transfers and interac-
tions (subjectively chosen by the author of this article).Theoretical Biology and Medical Modelling 2007, 4:45 http://www.tbiomed.com/content/4/1/45
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ated by specific through-space, pairwise interactions
between amino acid residues [20]. He suggested that
amino acids of specifically interacting proteins, in their
specifically interacting domains, are composed of two
parallel sequences of amino acid pairs that are spatially
complementary to each other, similarly to the Watson-
Crick base pairs in nucleic acids. The protein/nucleic acid
analogy in his theory was sustained and he proposed that
these spatially complementary amino acids are coded by
reverse-complementary codons (translational reading in
the 5'→3' direction).
It is possible to segregate 64 (the number of different
codons, including the three stop codons) of all the possi-
ble putative amino acid pairs (20 × 20/2 = 200) into three
non-overlapping groups [21].
Biro
I was also inspired by the complementarity of nucleic
acids and developed a theory of complementary coding of
specifically interacting amino acids [9-11]. I had no
knowledge of the publications of Mekler or Idlis (pub-
lished in two Russian papers). I was also convinced that
amino acid pairs coded by complementary codons
(whether in the same 5'→3'/5'→3' or opposite 5'→3'/
3'→5' orientations) are somehow special and suggested
that these pairs of amino acids might be responsible for
specific intra- and intermolecular peptide interactions.
I developed a method for pairwise computer searching of
protein sequences for complementary amino acids and
found that these specially coded amino acid pairs are sta-
tistically overrepresented in those proteins known to
interact with each other. In addition, I was able to find
short complementary amino acid sequences within the
same protein sequences and inferred that these might play
a role in the formation or stabilization of 3D protein
structures (Figure 3). Molecular modeling showed the size
compatibility of complementary amino acids and that
they might form bridges 5–7 atoms long between the
alpha C atoms of amino acids. It was a rather ambitious
theory at a time when the antisense DNA sequences were
called nonsense, and it was an even more ambitious
method when computers were programmed by punch-
cards and the protein databases were based on Dayhoff's
three volumes of protein sequences [8].
Blalock-Smith
This theory is called the molecular recognition theory; syno-
nyms are hydropathy complementarity or anti-complementa-
rity theory. It was based on the observation [22] that
codons for hydrophilic and hydrophobic amino acids are
generally complemented by codons for hydrophobic and
hydrophilic amino acids, respectively. This is the case
even when the complementary codons are read in the
3'→5"' direction. Peptides specified by complementary
RNAs bind to each other with specificity and high affinity
Origin of the Proteomic Code Figure 3
Origin of the Proteomic Code. Threonine (Thr) is coded by 4 different synonymous codons. Complementary triplets encode different 
amino acids in parallel (3'→5') and anti-parallel (5'→3') readings. Amino acids encoded by symmetrical codons are called "primary" and 
others "secondary" anti-sense amino acids (modified from [9].Theoretical Biology and Medical Modelling 2007, 4:45 http://www.tbiomed.com/content/4/1/45
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[23,24]. The theory turned out to be very fruitful in neuro-
endocrine and immune research [25,26].
A very important observation is that antibodies against
complementary antibodies also specifically interact with
each other. Bost and Blalock [27] synthesized two com-
plementary oligopeptides (i.e. peptides translated from
complementary mRNAs, in opposing directions). The two
peptides, Leu-Glu-Arg-Ile-Leu-Leu (LERILL), and its com-
plementary peptide, Glu-Leu-Cys-Asp-Asp-Asp
(ELCDDD), specifically recognized each other in radioim-
munoassay. Antibodies were produced against both pep-
tides. Each antibodies specifically recognized its own
antigen. Using radioimmunoassays, anti-ELCDDD anti-
bodies were shown to interact with 125I-labeled anti-
LERILL antibodies but not with 125I-labeled control anti-
bodies. More importantly, the interaction of the two anti-
bodies could be blocked using either peptide antigen, but
not by control peptides. Furthermore, 125I-labeled anti-
LERILL binding to LERILL could be blocked with anti-
ELCDDD antibody and vice versa. It was concluded there-
fore that antibody/antibody binding occurred at or near
the antigen combining site, demonstrating that this was
an idiotypic/anti-idiotypic interaction.
This experiment clearly showed the existence (and func-
tioning) of an intricate network of complementary pep-
tides and interactions. Much effort is being made to
master this network and use it in protein purification,
binding assays, medical diagnosis and therapy.
Recently, Blalock [28] has emphasized that nucleic acids
encode amino acid sequences in a binary fashion with
regard to hydropathy and that the exact pattern of polar
and non-polar amino acids, rather than the precise iden-
tity of particular R groups, is an important driver for pro-
tein shape and interactions. Perfect codon
complementarity behind the coding of interacting amino
acids is no longer an absolute requirement for his theory.
Amino acids translated from complementary codons
almost always show opposite hydropathy (Figure 4).
However, the validity of hydrophobe-hydrophyl interac-
tions remains unanswered.
Root-Bernstein
Another amino acid pairing hypothesis was presented by
Root-Bernstein [29,30]. He focused on whether it was
possible to build amino acid pairs meeting standard crite-
ria for bonding. He concluded that it was possible only in
26 cases (out of 210 pairs). Of these 26, 14 were found to
be genetically encoded by perfectly complementary
codons (read in the same orientation (5'→3'/3'→5')
while in 12 cases mismatch was found at the wobble posi-
tion of pairing codons.
Siemion
There is a regular connection between activation energies
(measured as enthalpies (ΔH++) and entropies (ΔS++) of
activation for the reaction of 18 N"-hydroxysuccinimide
esters of N-protected proteinaceous amino acids with p-
anisidine) and the genetic code [31-33]. This periodic
change of amino acid reactivity within the genetic code
led him to suggest a peptide-anti-peptide pairing. This is
rather similar to Root-Bernstein's hypothesis.
Miller
Practical use is the best test of a theory. Technologies
based on interacting proteins have a significant market in
different branches of biochemistry, as well as in medical
diagnostics and therapy. The Genetic Therapies Centre
(GTC) at the Imperial College (London, UK) founded in
2001 with major financial support from a Japanese com-
pany, the Mitsubishi Chemical Corporation, and the UK
charity, the Wolfson Foundation), is one of the first aca-
demic centers that are openly investing in Proteomic
Code-based technologies. With the clear intention that
their science "be used in the marketplace", Andrew Miller,
the first director of GTC and co-founder of its first spin-off
company, Proteom Ltd, is making major contributions to
this field [34-38].
However, Miller and his colleagues came to realize that
the amino acid pairs provided by perfectly complemen-
tary codons are not always the best pairs, and deviations
from the original design sometimes significantly
improved the quality of a protein-protein interaction.
Therefore the current view of Miller is that there are "stra-
tegic pairs of amino acid residues that form part of a new,
through-space two-dimensional amino acid interaction
code (Proteomic Code). The proteomic code and deriva-
tives thereof could represent a new molecular recognition
code relating the 1D world of genes to the 3D world of
protein structure and function, a code that could shortcut
and obviate the need for extensive research into the pro-
teome to give form and function to currently available
genomic information (i.e., true functional genomics)".
The Proteomic Code and the 3D structure of proteins
It is widely accepted that the 3D structures of proteins play
a significant role in their specific interactions and func-
tion. The opposite is less obvious, namely that specific
and individual amino acid pairs or sequences of these
pairs might determine the foldings of proteins. Comple-
mentarity at the amino acid level in the proteins, and the
corresponding internal complementarity within the cod-
ing mRNA (the Proteomic Code), raise the intriguing pos-
sibility that some protein folding information is present
in the nucleic acids (in addition to or within the known
and redundant genetic code). Real protein sequences
show a higher frequency of complementarily codedTheoretical Biology and Medical Modelling 2007, 4:45 http://www.tbiomed.com/content/4/1/45
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Hydropathy profile of a protein Figure 4
Hydropathy profile of a protein. An artificially constructed nucleic acid sequence was randomized and translated in the four possible 
directions (D, direct; RC, reverse-complementary; R, reverse; C, complementary). The D sequence was designed to contain equal num-
bers of the 20 amino acids.Theoretical Biology and Medical Modelling 2007, 4:45 http://www.tbiomed.com/content/4/1/45
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amino acids than translations of randomized nucleotide
sequences. [9-11]. The internal amino acid complementa-
rity allows the polypeptides encoded by complementary
codons to retain the secondary structure patterns of the
translated strand (mRNA). Thus, genetic code redundancy
could be related to evolutionary pressure towards reten-
tion of protein structural information in complementary
codons and nucleic acid subsequences [39-44].
Experimental evidence
Experiments based on the idea of a Proteomic Code usu-
ally start with a well-known receptor-ligand type protein
interaction. A short sequence is selected (often <10 amino
acids long) that is known or suspected to be involved in
direct contact between the proteins in question (P-P/r). A
complementary oligopeptide sequence is derived using
the known mRNA sequence of the selected protein
epitope, making a reverse complement of the sequence,
translating it and synthesizing it.
The flow of the experiments is as follows:
(a) choose an interesting peptide;
(b) select a short, "promising" oligo-peptide epitope (P);
(c) find the true mRNA of P;
(d) reverse-complement this mRNA;
(e) translate the reverse-complemented mRNA into the
complementary peptide (P/c);
(f) test P-P/c interaction (affinity, specificity);
(g) use P/c to find P-like sequences (for histochemistry,
affinity purification);
(h) use P/c to generate antibodies (P/c_ab);
(i) test P/c_ab for its interaction with the P-receptor (P/r)
and use it for (e.g.) labeling or affinity purification of P/r;
(j) use P_ab (as well as antibodies to P, P_ab) to find and
characterize idiopathic (P_ab-P/c_ab) antibody reactions.
An encouraging feature of Proteomic-Code based technol-
ogy is that the amino acid complementarity (information
mirroring) does not stop with the P-P/c interaction but
continues and involves even the antibodies generated
against the original interacting domains; even P_ab-P/
c_ab, i.e., antibodies against interacting proteins, will
themselves contain interacting domains. They are idio-
types.
Peptides and interactions involved in Proteomic Code-
based experiments are summarized in Figure 5.
An impressive example of this technology and its poten-
tial is given by Bost and Blalock [27] (described above), It
is reviewed by Heal et al. [37] and McGuian [45]. A collec-
tion of examples [see Additional file 1] presents a number
of experiments of this kind.
Some experiments or types of experiments require further
attention.
The antisense homology box, a new motif within proteins
that encodes biologically active peptides, was defined by
Baranyi and coworkers around 1995. They used a bioin-
formatics method for a genome-wide search of peptides
encoded by complementary exon sequences. They found
that amphiphilic peptides, approximately 15 amino acids
in length, and their corresponding antisense peptides exist
within protein molecules. These regions (termed anti-
sense homology boxes) are separated by approximately
50 amino acids. They concluded that because many sense-
antisense peptide pairs have been reported to recognize
and bind to each other, antisense homology boxes may be
involved in folding, chaperoning and oligomer formation
of proteins. The frequency of peptides in antisense homol-
ogy boxes was 4.2 times higher than expected from ran-
dom sequences (p < 0.001) [46].
They successfully confirmed their suggestion by experi-
ments. The antisense homology box-derived peptide
CALSVDRYRAVASW, a fragment of the human endothe-
lin A receptor, proved to be a specific inhibitor of
endothelin peptide (ET-1) in a smooth muscle relaxation
assay. The peptide was also able to block endotoxin-
induced shock in rats. The finding of an endothelin recep-
tor inhibitor among antisense homology box-derived
peptides indicates that searching proteins for this new
motif may be useful in finding biologically active peptides
[47-49].
A bioinformatics experiment similar to Baranyi's was per-
formed by Segerstéen et al. [50]. They tested the hypothe-
sis that nucleic acids, encoding specifically-interacting
receptor and ligand proteins contain complementary
sequences. Human insulin mRNA (HSINSU) contained
16 sequences that were 23.8 ± 1.4 nucleotides long and
were complementary to the insulin receptor mRNA
(HSIRPR, 74.8 ± 1.9% complementary matches, p < 0.001
compared to randomly-occurring matches). However,
when 10 different nucleic acids (coding proteins not inter-
acting with the insulin receptor) were examined, 81 addi-
tional sequences were found that were also
complementary to HSIRPR. Although the finding of short
complementary sequences was statistically highly signifi-Theoretical Biology and Medical Modelling 2007, 4:45 http://www.tbiomed.com/content/4/1/45
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cant, we concluded that this is not specific for nucleic acid
coding of specifically interacting proteins.
There are two kinds of antisense technologies based on
the complementarity of nucleic acids: (a) when the pro-
duction of a protein is inhibited by an oligonucleotide
sequence complementary to its mRNA; this is a pre-trans-
lational modification and it usually requires transfer of
nucleic acids into the cells; (b) when the biological effect
of an already complete protein is inhibited by another
protein translated from its complementary mRNA; this is
a post-translational modification and does not block the
synthesis of a protein.
Many experiments [see Additional file 1] indicate that
antisense proteins inhibit the biological effects of a pro-
tein. This suggests the possibility of antisense protein ther-
apy. The P-P/c reaction is in many respects similar to the
antigen-antibody reaction, therefore the potential of anti-
sense protein therapy is expected to be similar to the
potential of antibody therapy (passive immunization
against proteinaceous toxins, such as bacterial toxins, ven-
oms, etc.). However, antisense peptides are much smaller
than antibodies (MW as little as ~1000 Da compared to
IgG ~155 kDa). This means that antisense proteins are
easy to manufacture in vitro; antibodies are produced in
living animals (with non-human species characteristics).
However, the small size is expected to have the disadvan-
tage of a lower Kd and a shorter biological half-life.
Immunization with complementary peptides produces
antibodies (P/c_ab) as with any other protein. These anti-
bodies contain a domain that is similar to the original
protein (P) and specifically binds to the receptor of the
original protein (P/r). This property is effectively used for
affinity purification or immuno-staining of receptors. The
P/c_ab is able to mimic or antagonize the in vivo effect of
P by binding to its receptor. This property has the desired
potential to treat protein-related diseases such as many
pituitary gland-related diseases. A vision might be to treat,
Variations for a protein Figure 5
Variations for a protein. Experiments regarding the Proteomic Code are usually designed for the peptides and peptide interactions 
depicted in this figure. A peptide (P) naturally interacts with its receptor (P/r). Antibodies against this protein (P/ab) and its receptor (P/
r_ab) might also be naturally present in vivo as part of the immune surveillance or might arise artificially. The Proteomic Code provides a 
method for designing artificial oligopeptides (P/c and P/rc) that can interact strongly with the receptor and its ligand. P and P/c as well as 
Pr and P/rc are expressed from complementary nucleic acid sequences. It is possible to raise antibodies against P/c (P/c_ab) and P/rc (P/
rc_ab).Theoretical Biology and Medical Modelling 2007, 4:45 http://www.tbiomed.com/content/4/1/45
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for example, pituitary dwarfism, with immunization
against growth hormone complementary peptide (GH/c),
or Type I diabetes with immunization against insulin/c
peptide.
Reverse but not complementary sequences
The biochemical process of transcription and translation
is unidirectional, 5'→3', and reversion does not exist.
However, there are many examples of sequences present
in the genome (in addition to direct reading) in reverse
orientation, and if expressed (in the usual 5'→3' direc-
tion) they produce mRNA and proteins that are, in effect,
reversely transcribed and reversely translated.
An interesting observation is that direct and reverse pro-
teins often have very similar binding properties and
related biological effects even if their sequence homology
is very low (<20%). For example, growth hormone-releas-
ing hormone (GHRH) and the reverse GNRH specifically
bind to the GHRH receptor on rat pituitary cells and to
polyclonal anti-GHRH antibody in ELISA and RIA proce-
dures although they share only 17% sequence similarity
and they are antagonists in in vitro stimulation of GH
RNA synthesis and in vitro and in vivo GH release from
pituitary cells [51].
The same phenomenon is observed in complementary
sequences. A peptide expressed by complementary mRNA
often specifically interacts with proteins expressed by the
direct mRNA and it does not matter if they are read in the
same or opposite directions. A possible explanation is that
many codons are actually symmetrical and have the same
meaning in both directions of reading. The physico-chem-
ical properties of amino acids are preferentially deter-
mined by the 2nd (central) codon letter [52] so the
physico-chemical pattern of direct and reverse sequences
remains the same. In addition, I found that protein struc-
tural information is also carried by the 2nd codon letters
[53].
Controversies regarding the original Proteomic Codes
All proteomic codes before 2006 required perfect comple-
mentarity, even if it was noticed that the "biophysical and
biological properties of complementary peptides can be
improved in a rational and logical manner where appro-
priate" [36].
- Expression of the antisense DNA strand was simply not
accepted before large scale genome sequences confirmed
that genes are about equally distributed on both strands of
DNA in all organisms containing dsDNA.
- Spatial complementarity is difficult to imagine between
longer amino acid sequences, because the natural, inter-
nal folding of proteins will prohibit it in most cases.
- Usually, residues with the same polarity are attracted to
each other, because hydrophobes prefer a hydrophobic
environment and lipophobes prefer lipophobic neigh-
bors. Amphipathic interactions seem artificial to most
chemists.
- Only complementary (but not reversed) sequences were
found as effective as direct ones. This requires 3'→5' trans-
lation, which is normally prohibited.
- The results are inconsistent; it works for some proteins
but not for others; it is necessary to improve results, e.g.,
"M-I pair mutagenesis" [36].
- Protein 3D structure and interactions are thought to be
arranged on a larger scale than individual amino acids.
- The number of possible amino acid pairs is 20 × 20/2 =
200. The number of perfect codons is 64, i.e., about a third
of the number expected. This means that two-thirds of
amino acid pairs are impossible to encode in perfectly
complementary codons.
￿ are these amino acid pairs not derived from comple-
mentary codons at all?
￿ are these amino acid pairs derived from imperfectly
complementary codons?
Development of the second generation 
Proteomic Code
What did we learn about the Proteomic Code during its
first 25 years (1981–2006)? My first and most important
lesson is that I realize how terribly wrong it was (and is)
to believe in scientific dogmas, such as sense vs nonsense
DNA strands. It is almost unbelievable today that many of
us were able to see a difference between two perfectly sym-
metrical and structurally identical strands.
We were able to provide multiple independent strands of
convincing evidence that the concept of the Proteomic
Code is valid. At the same time we had to understand that
the first concepts – based on perfect complementarity of
codons behind interacting amino acids – were imperfect.
There is protein folding information in the nucleic acids –
in addition to or within the redundant genetic code – but
it is unclear how is it expressed and interpreted to form the
3D protein structure.
A major physico-chemical property, the hydropathy of
amino acids, is encoded by the codons. Proteins trans-
lated from direct and reverse as well as from complemen-
tary and reverse-complementary strands have the same
hydropathic profiles. This is possible only if the aminoTheoretical Biology and Medical Modelling 2007, 4:45 http://www.tbiomed.com/content/4/1/45
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acid hydropathy is related to the second, central codon
letter.
There is a clear indication that some biological informa-
tion exists in multiple complementary (mirror) copies:
DNA-DNA/c→RNA-RNA/c→protein-protein/c→IgG-
IgG/c.
Some theoretical considerations and research that led to
the suggestion of the 2nd generation Proteomic Codes are
now reviewed.
Construction of a Common Periodic Table of Codons and 
Amino Acids
The Proteomic Code revitalizes a very old dilemma and
dispute about the origin of the genetic code, represented
by Carl Woese and Francis Crick. Is there any logical con-
nection between any properties of an amino acid on the
one hand and any properties of its genetic code on the
other?
Carl Woese [54] argued that there was stereochemical
matching, i.e., affinity, between amino acids and certain
triplet sequences. He therefore proposed that the genetic
code developed in a way that was very closely connected
to the development of the amino acid repertoire, and that
this close biochemical connection is fundamental to spe-
cific protein-nucleic acid interactions.
Crick [55] considered that the basis of the code might be
a "frozen accident", with no underlying chemical ration-
ale. He argued that the canonical genetic code evolved
from a simpler primordial form that encoded fewer
amino acids. The most influential form of this idea, "code
co-evolution," proposed that the genetic code co-evolved
with the invention of biosynthetic pathways for new
amino acids [56].
A periodic table of codons has been designed in which the
codons are in regular locations. The table has four fields
(16 places in each), one with each of the four nucleotides
(A, U, G, C) in the central codon position. Thus, AAA
(lysine), UUU (phenylalanine), GGG (glycine) and CCC
(proline) are positioned in the corners of the fields as the
main codons (and amino acids). They are connected to
each other by six axes. The resulting nucleic acid periodic
table shows perfect axial symmetry for codons. The corre-
sponding amino acid table also displaces periodicity
regarding the biochemical properties (charge and hydrop-
athy) of the 20 amino acids, and the positions of the stop
signals. Figure 6 emphasizes the importance of the central
nucleotide in the codons, and predicts that purines con-
trol the charge while pyrimidines determine the polarity
of the amino acids.
In addition to this correlation between the codon
sequence and the physico-chemical properties of the
amino acids, there is a correlation between the central res-
idue and the chemical structure of the amino acids. A cen-
tral uridine correlates with the functional group -C(C)2-; a
central cytosine correlates with a single carbon atom, in
the C1 position; a central adenine coincides with the func-
tional groups -CC = N and -CC = O; and finally a central
guanine coincides with the functional groups -CS, -C = O,
and C = N, and with the absence of a side chain (glycine).
(Figure 7)
I interpret these results as a clear-cut answer for the Woese
vs Crick dilemma: there is a connection between the
codon structure and the properties of the coded amino
acids. The second (central) codon base is the most impor-
tant determinant of the amino acid property. It explains
why the reading orientation of translation has so little
effect on the hydropathy profile of the translated peptides.
Note that 24 of 32 codons (U or C in the central position)
code apolar (hydrophobic) amino acids, while only 1 of
32 codons (A or G in the central position) codes non-apo-
lar (non-hydrophobic, charged or hydrophilic) amino
acids. It explains why complementary amino acid
sequences have opposite hydropathy, even if the binary
hydropathy profile is the same.
The physico-chemical compatibility of amino acids in the 
Proteomic Code
Complementary coding of two amino acids is not a guar-
antee per se of the special co-location (or interaction) of
these amino acids within the same or between two differ-
ent peptides. Some kind of physico-chemical attraction is
also necessary. The most fundamental properties to con-
sider are, of course, the size, charge and hydropathy. Mek-
ler and I suggested size compatibility [9-11,20], obviously
under the influence of the known size complementarity of
the Watson-Crick base pairs. Blalock emphasized the
importance of hydropathy, or rather amphipathy (which
makes some scientists immediately antipathic). Hydro-
phobic residues like other hydrophobic residues and
hydrophilic residues like hydrophilic residues. Hydrophyl
and hydrophobe residues have difficulties to share the
same molecular environment.
Visual studies of the 3D structures of proteins give some
ideas of how interacting interfaces look (Figure 8):
- the interacting (co-locating) sequences are short (1–10
amino acid long);
- the interacting (co-locating) sequences are not continu-
ous; there are many mismatches;Theoretical Biology and Medical Modelling 2007, 4:45 http://www.tbiomed.com/content/4/1/45
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- the orientations of co-locating residues are often not the
same (not parallel);
- the contact between co-locating residues might be side-
to-side or top-to-top.
This is clearly a different picture from the base-pair inter-
actions in a dsDNA spiral. Alpha-helices and beta-sheets
are regular structures, which make their amino acid resi-
dues periodically ordered. Many residues are parallel to
each other and W-C-like interactions are not impossible.
But is it really the explanation for specific residue interac-
tions?
SeqX
The interacting residues of protein and nucleic acid
sequences are close to each other; they are co-located.
Structure databases (e.g., Protein Data Bank, PDB and
Nucleic Acid Data Bank, NDB) contain all the informa-
tion about these co-locations; however, it is not an easy
task to penetrate this complex information. We developed
a JAVA tool, called SeqX, for this purpose [57]. The SeqX
tool is useful for detecting, analyzing and visualizing resi-
due co-locations in protein and nucleic acid structures.
The user:
(a) selects a structure from PDB;
Common Periodic Table of Codons & Amino Acids (modified from [52]) Figure 6
Common Periodic Table of Codons & Amino Acids (modified from [52]).Theoretical Biology and Medical Modelling 2007, 4:45 http://www.tbiomed.com/content/4/1/45
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Effects of a single codon residue on the structure of the amino acids Figure 7
Effects of a single codon residue on the structure of the amino acids.Theoretical Biology and Medical Modelling 2007, 4:45 http://www.tbiomed.com/content/4/1/45
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(b) chooses an atom that is commonly present in every
residue of the nucleic acid and/or protein structure(s);
(c) defines a distance from these atoms (3–15 Å).
The SeqX tool then detects every residue that is located
within the defined distances from the defined "backbone"
atom(s); provides a dot-plot-like visualization (residues
contact map); and calculates the frequency of every possi-
ble residue pair (residue contact table) in the observed
structure. It is possible to exclude ± 1–10 neighbor resi-
dues in the same polymeric chain from detection, which
greatly improves the specificity of detections (up to 60%
when tested on dsDNA). Results obtained on protein
structures show highly significant correlations with results
obtained from the literature (p < 0.0001, n = 210, four dif-
ferent subsets). The co-location frequency of physico-
chemically compatible amino acids is significantly higher
than is calculated and expected for random protein
sequences (p < 0.0001, n = 80) (Figure 9).
These results gave a preliminary confirmation of our
expectation that physico-chemical compatibility exists
between co-locating amino acid pairs. Our findings do
Amino acid co-locations Figure 8
Amino acid co-locations. Randomly selected amino acid contacts from real proteins. The interactions between amino acid residues from 
2 (A, B) 3 (C, D) and 4 (E, F) parallel alpha helices are perpendicular to the peptide backbones (helices). The orientations of residues 
show considerable variation; some are located side-by-side, others are end-to-end.Theoretical Biology and Medical Modelling 2007, 4:45 http://www.tbiomed.com/content/4/1/45
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not support any significant dominance of amphipathic
residue interactions in the structures examined.
Amino acid size, charge, hydropathy indices and matrices 
for protein structure analysis
It was necessary to look more closely at the physico-chem-
ical compatibility of co-locating amino acids [58].
We indexed the 200 possible amino acid pairs for their
compatibility regarding the three major physico-chemical
properties – size, charge and hydrophobicity – and con-
structed size, charge and hydropathy compatibility indi-
ces (SCI, CCI, HCI) and matrices (SCM, CCM, HCM).
Each index characterized the expected strength of interac-
tion (compatibility) of two amino acids by numbers from
1 (not compatible) to 20 (highly compatible). We found
statistically significant positive correlations between these
indices and the propensity for amino acid co-locations in
real protein structures (a sample containing a total of
34,630 co-locations in 80 different protein structures): for
HCI, p < 0.01, n = 400 in 10 subgroups; for SCI, p < 1.3E-
08, n = 400 in 10 subgroups; for CCI, p < 0.01, n = 175).
Size compatibility between residues (well known to exist
in nucleic acids) is a novel observation for proteins (Fig-
ure 10).
We tried to predict or reconstruct simple 2D representa-
tions of 3D structures from the sequence using these
matrices by applying a dot-plot-like method. The loca-
tions and patterns of the most compatible subsequences
were very similar or identical when the three fundamen-
tally different matrices were used, which indicates the
consistency of physico-chemical compatibility. However,
it was not sufficient to choose one preferred configuration
between the many possible predicted options (Figure 11).
Indexing of amino acids for major physico-chemical
properties is a powerful approach to understanding and
assisting protein design. However, it is probably insuffi-
cient itself for complete ab initio structure prediction.
Anfinsen's thermodynamic principle and the Proteomic 
Code
The existence of physico-chemical compatibility of co-
locating amino acids even on the single residue level is, of
course, a necessary support for the Proteomic Code. At the
same time, it raises the possibility that protein structure
might be predicted from the primary amino acid sequence
(de novo, ab initio prediction) and the location of phys-
ico-chemically compatible amino acid residues in the
sequence. This idea is in line with a dominating statement
about protein folding: Anfinsen's thermodynamic princi-
ple states that all information necessary to form a 3D pro-
tein structure is present in the protein sequence [59].
Attempts were made to use the three different matrices in
a dot plot to predict the place and extent of the most likely
residue co-locations. This visual, non-quantitative
method indicated that the three very different matrices
located very similar residues and subsequences as poten-
tial co-location places. No single diagonal line was seen in
the dot-plot matrices, which is the expected signature of
sequence similarity (or compatibility in our case).
Instead, block-like areas indicated the place and extent of
predicted sequence compatibilities. It was not possible to
reconstruct a real map of any protein 2D structure (Figure
11) [60].
This experience with the indices provides arguments for as
well as against Anfinsen's theorem. The clear-cut action of
basic physico-chemical laws at the residue level is well in
line with the lowest free energy requirement of the law of
entropy. Furthermore, this obvious presence of physico-
chemical compatibility is easy to understand, even from
an evolutionary perspective. In evolution, sequence
changes more rapidly than structure; however, many
sequence changes are compensatory and preserve local
physico-chemical characteristics. For example, if, in a
given sequence, an amino acid side chain is particularly
bulky with respect to the average at a given position, this
might have been compensated in evolution by a particu-
Real vs calculated residue co-locations (from [57]) Figure 9
Real vs calculated residue co-locations (from [57]). The relative 
frequency of real residue co-locations was determined by SeqX in 
80 different protein structures and compared to the relative fre-
quency of calculated co-locations in artificial, random protein 
sequences (C). The 200 possible residue pairs provided by the 20 
amino acids were grouped into 4 subgroups on the basis of their 
mutual physico-chemical compatibility, i.e., favored (+) and un-
favored (-) in respect of hydrophobicity and charge. (HP+, hydro-
phobe-hydrophobe and lipophobe-lipophobe; HP-, hydrophobe-
lipophobe; CH+, positive-negative and hydrophobe-charged; CH-: 
positive-positive, negative-negative and lipophobe-charged interac-
tions). The bars represent the mean ± SEM (n = 80 for real struc-
tures and n = 10 for artificial sequences). Student's t-test was 
applied to evaluate the results.Theoretical Biology and Medical Modelling 2007, 4:45 http://www.tbiomed.com/content/4/1/45
Page 15 of 44
(page number not for citation purposes)
larly small side chain in a neighboring position, to pre-
serve the general structural motif. Similar constraints
might hold for other physico-chemical quantities such as
amino acid charge or hydrogen bonding capacity [61].
We were not able to reconstruct any structure using our
indices. There are massive arguments against Anfinsen's
principle:
(1) The connection between primary, secondary and terti-
ary structure is not strong, i.e., in evolution, sequence
Amino acid co-locations vs size, charge, and hydrophobe compatibility indexes (modified from [58]) Figure 10
Amino acid co-locations vs size, charge, and hydrophobe compatibility indexes (modified from [58]). Individual data (left) Average pro-
pensity of the 400 different amino acid co-locations in 80 different protein structures (SeqX 80) are plotted against size, charge and 
hydrophobe compatibility indexes (SCI, CCI, HCI). The original "row" values are indicated in (A-C). The SeqX 80 values were corrected 
by the co-location values, which are expected only by chance in proteins where the amino acid frequency follows the natural codon fre-
quency (NF) (D-F). Individual data (left) were divided into subgroups and summed (Sum) (Groupped data, right). The group averages are 
connected by the blue lines while the pink symbols and lines indicate the calculated linear regression.Theoretical Biology and Medical Modelling 2007, 4:45 http://www.tbiomed.com/content/4/1/45
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Matrix representation of residue co-locations in a protein structure (1AP6) (modified from [58]) Figure 11
Matrix representation of residue co-locations in a protein structure (1AP6) (modified from [58]). A protein sequence (1AP6) was com-
pared to itself with DOTLET using different matrices, SCM (A), CCM (B), HCM (C), the combined SCHM (D) and NFM (G) and 
Blosum62 (F). Comparison of randomized 1AP6 using SCHM is seen in (I). The 2D (SeqX Residue Contact Map) and 3D (DeepView/
Swiss-PDB Viewer) views of the structure are illustrated in (E) and (H). The black/gray parts of the dot-plot matrices indicate the respec-
tive compatible residues, except the Blosum62 comparison (F), where the diagonal line indicates the usual sequence similarity. The dot-
plot parameters are otherwise the same for all matrices.Theoretical Biology and Medical Modelling 2007, 4:45 http://www.tbiomed.com/content/4/1/45
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changes more rapidly than structure. Structure is often
conserved in proteins with similar function even when
sequence similarity is already lost (low structure specifi-
city to define a sequence). Identical or similar sequences
often result in different structures (low sequence specifi-
city to define a structure).
(2) An unfolded protein has a vast number of accessible
conformations, particularly in its residue side chains.
Entropy is related to the number of accessible conforma-
tions. This problem is known as the Levinthal paradox
[62].
(3) The energy profile characteristics of native and
designed proteins are different. Native proteins usually
show a unique and less stable profile, while designed pro-
teins show lower structural specificity (many different
possible structures) but high stability [63].
(4) The entropy minimum is a statistical minimum. The
conformation entropy change of the whole molecule is
the sum of local (residue level) conformation entropy
changes and it permits many different local conformation
variations to co-exist. It is doubtful whether structural var-
iability (heterogeneity, instability) is compatible with the
function (homogeneity, stability) of a biologically active
molecule.
The present experiments do not decide the "fate" of Anfin-
sen's dogma; however, they show that the number of pos-
sible co-locating places is too large, and searching this
space poses a daunting optimization problem. It is not
realistic to expect the ab initio prediction of only one sin-
gle structure from one primary protein sequence. The
development of a prediction tool for protein structure
(like an mfold for nucleic acids [64], that provides only a
few hundred most likely (thermodynamically most opti-
mal) structure suggestions per protein sequence seems to
be closer. It is likely that SCM, CCI and HCM (or similar
matrices) will be essential elements of these tools.
Additional folding information might be necessary (in
addition to that carried in the protein primary sequence)
to be able to create a unique protein structure. Such infor-
mation is suspected to be present in the redundant genetic
code [65-67].
Protein structure and the functional asymmetry of the 
codons
I agree with Levinthal that the Anfinsen's thermodynamic
principle is insufficient.
There are two potential, external sources of additional and
specific protein folding information: (a) the chaperons
(other proteins that assist in the folding of proteins and
nucleic acids [70]); and (b) the protein-encoding nucleic
acid sequences themselves (which are the templates for
protein syntheses but are not defined as chaperons).
The idea that the nucleotide sequence itself could modu-
late translation and hence affect the co-translational fold-
ing and assembly of proteins has been investigated in a
number of studies [71,72]. Studies on the relationships
between synonymous codon usage and protein secondary
structural units are especially popular [67,73,74]. The
genetic code is redundant (61 codons encode 20 amino
acids) and as many as 6 synonymous codons can encode
the same amino acid (Arg, Leu, Ser). The "wobble" base
has no effect on the meaning of most codons, but codon
usage (wobble usage) is still not randomly defined
[75,76] and there are well known, stable species-specific
differences in codon usage. It seems logical to search for
some meaning (biological purpose) of the wobble bases
and try to associate them with protein folding.
Another observation concerning the code redundancy
dilemma is that there is a widespread selection (prefer-
ence) for local RNA secondary structure in protein coding
regions [77]. A given protein can be encoded by a large
number of distinct mRNA species, potentially allowing
mRNAs to optimize desirable RNA structural features
simultaneously with their protein coding function. The
immediate question is whether there is some logical con-
nection between the possible, optimal RNA structures and
the possible, optimal biologically active protein struc-
tures.
Single-stranded RNA molecules can form local secondary
structures through the interactions of complementary seg-
ments. W-C base pair formation lowers the average free
energy, dG, of the RNA and the magnitude of change is
proportional to the number of base pair formations.
Therefore the free folding energy (FFE) is used to charac-
terize the local complementarity of nucleic acids [77]. The
free folding energy is defined as FFE = {(dGshuffled - dGna-
tive)/L} × 100, where L is the length of the nucleic acid, i.e.,
the free energy difference between native and shuffled
(randomized) nucleic acids per 100 nucleotides. Higher
positive values indicate stronger bias towards secondary
structure in the native mRNA, and negative values indicate
bias against secondary structure in the native mRNA.
We used a nucleic acid secondary structure predicting
tool, mfold [64], to obtain dG values and the lowest dG
was used to calculate the FFE. mfold also provided the
folding energy dot-plots, which are very useful for visual-
izing the energetically most favored structures in a 2D
matrix.Theoretical Biology and Medical Modelling 2007, 4:45 http://www.tbiomed.com/content/4/1/45
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A series of JAVA tools were used: SeqX to visualize the pro-
tein structures in 2D as amino acid residue contact maps
[57]; SeqForm for selection of sequence residues in prede-
fined phases (every third in our case) [78]; SeqPlot for fur-
ther visualization and statistical analyses of the dot-plot
views [79]; Dotlet as a standard dot-plot viewer [80].
Structural data were downloaded from PDB [81], NDB
[82], and from a wobble base oriented database called
Integrated Sequence-Structure Database (ISSD) [83].
Structures were generally randomly selected in regard to
species and biological function (a few exceptions are men-
tioned below). Care was taken to avoid very similar struc-
tures in the selections. A propensity for alpha helices was
monitored during selection and structures with very high
and very low alpha helix content were also selected to
ensure a wide range of structural representation.
Linear regression analyses and Student's t-tests were used
for statistical analyses of the results.
Observations were made on human peptide hormone
structures. This group of proteins is very well defined and
annotated, the intron-exon boundaries are known and
even intron data are easily accessible. The coding
sequences were phase separated by SeqForm into three
subsequences, each containing only the 1st, 2nd or 3rd
letters of the codons. Similar phase separation was made
for intronic sequences immediately before and after the
exon. There are, of course, no known codons in the
intronic sequences, therefore we continued the same
phase that we applied for the exon, assuming that this
kind of selection is correct, and maintained the name of
the phase denotation even for non-coding regions. Subse-
quences corresponding to the 1st and 3rd codon letters in
the coding regions had significantly higher FFEs than sub-
sequences corresponding to the 2nd codon letters. No
such difference was seen in non-coding regions (Figure
12).
In a larger selection of 81 different protein structures, the
corresponding protein and coding sequences were used to
extend the observations. These 81 proteins represented
different (randomly selected) species and different (also
randomly selected) protein functions and therefore the
results might be regarded as more generally valid. The pro-
pensity for different secondary structure elements was
recorded (as annotated in different databases) (Figure
13).
The proportion of alpha helices varied from 0 to 90% in
the 81 proteins and showed a significant negative correla-
tion to the proportion of beta sheets (Figures 14 and 15).
The original observation made on human protein hor-
mones, that significantly more free folding energy is asso-
ciated with the 1st and 3rd codon residues than with the
Frequency of protein structure elements Figure 13
Frequency of protein structure elements. Box plot representation 
of protein secondary structure elements in 81 structures. L = 317 
± 20 (mean ± SEM, n = 81). Secondary structure codes: H, alpha 
helix; B, residue in isolated beta bridge; E, extended strand, partic-
ipates in beta ladder; G, 3-helix (3/10 helix); I, 5 helix (pi helix); P, 
polyproline type II helix (left-handed); T, hydrogen bonded turn; S, 
bend.
Free folding energies (FFE) in different codon residues of  human genes Figure 12
Free folding energies (FFE) in different codon residues of human 
genes. The coding sequences (exons) of 18 human hormone genes 
and the preceding (-1) and following (+1) sequences (introns) 
were phase separated into three subsequences each correspond-
ing to the 1st, 2nd and 3rd codon positions in the coding 
sequence. The dG values were determined by mfold and the FFE 
was calculated. Each bar represents the mean ± SEM, n = 18.Theoretical Biology and Medical Modelling 2007, 4:45 http://www.tbiomed.com/content/4/1/45
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2nd, was confirmed on a larger and more heterogeneous
protein selection. A significant difference was apparent
even between the 1st and 3rd residues in this larger selec-
tion (Figure 16).
There is a correlation between the protein structure and
the FFE associated with codon residues. The correlation is
negative between the FFEs associated with the 2nd (mid-
dle) codon residues and the alpha helix content of the
protein structure. The correlation is especially significant
when the FFE ratios are compared to the helix/sheet ratios
(Figures 17 and 18). The alpha helix is the most abundant
structural element in proteins. It shows negative correla-
tion to the frequency of the second most prominent pro-
tein structure, the beta sheet. The propensity for some
amino acids and the major physico-chemical characteris-
tics (charge and polarity) show significant correlation
(positive or negative) to this structural feature. We include
statistical analyses of alpha helix content and other pro-
tein characteristics to show the complexity behind the
term "alpha helix" and to demonstrate the insecurity in
interpreting any correlation to this structural feature (Fig-
ures 19 and 20). Detailed analyses of these data are out-
with the scope of this review.
That the FFE in subsequences of 1st and 3rd codon resi-
dues is higher than in the 2nd indicates the presence of a
larger number of complementary bases at the right posi-
tions of these subsequences. However, this might be the
case only because the first and last codons form simpler
subsequences and contain longer repeats of the same
nucleotide than the 2nd codons. This would not be sur-
prising for the 3rd (wobble) base but would not be
expected for the 1st residue, even though the central
codon letters are known to be the most important for dis-
tinguishing between amino acids (as shown in the Com-
mon Periodic Table of Codons and Amino Acids [52]. It is
more significant that the FFEs in 1st and 3rd residues are
additive and together they represent the entire FFE of the
intact mRNA (Figure 21).
That the FFE at the 1st and 3rd codon positions is higher
than at 2nd also indicates that the number of complemen-
tary bases (a-t and g-t) is higher in the 1st and 3rd subse-
quences than in the second. This is possible only if more
complementers are in 1-1, 1-3, 3-1, 3-3 position pairs
than in 1-2, 2-1, 2-3, 3-2 position pairs. We wanted to
know whether the 1-1, 3-3 (complement) or the 1-3, 3-1
(reverse-complement) pairing is more predominant.
The length of phase-separated nucleic acid subsequences
(l) is a third of the original coding sequence (L). The
number of different residues (a, t, g, and c) varies at differ-
ent codon positions (1, 2, 3).
a1 + u1 + g1 + c1 = a2 + t2 + g2 + c2 = a3 + t3 + g3 + c3 = 
l = L/3
The highest number of complementary pairs might occur
in the 1st subsequence if
a1 = t1, g1 = c1 and a1/t1 = g1/c1 = 1
If, for example, a1 > t1, g1 = c1 an excess of unpaired a1
occurs and a1/t1 > g1/c1 = 1 and the possible FFE in sub-
sequence 1 will be lower. Following the same logic for
Correlation between two main structural elements in pro- teins Figure 15
Correlation between two main structural elements in proteins. 
Data were taken from Figure 14 (H, alpha helix; E, beta sheet).
Frequency of secondary structure elements Figure 14
Frequency of secondary structure elements. The propensity of dif-
ferent structural elements in 81 different proteins is shown. L = 
317 ± 20 (mean ± SEM, n = 81). Secondary structure codes: H, 
alpha helix; B, residue in isolated beta bridge; E, extended strand, 
participates in beta ladder; G, 3-helix (3/10 helix); I, 5 helix (pi 
helix); P, polyproline type II helix (left-handed); T, hydrogen 
bonded turn; S, bend.Theoretical Biology and Medical Modelling 2007, 4:45 http://www.tbiomed.com/content/4/1/45
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other pairs in other subsequences we can conclude that
any deviation from a/t = g/c = 1 is suboptimal regarding
the FFE. Counting the different residue ratios and combi-
nations indicates that the optima are obtained if the resi-
dues in the first position form W-C pairs with residues at
the third positions (1-3) and vice versa (3-1). This is con-
sistent with the expectation that mRNA will form local
loops, in which the direction of more or less double
Free folding energy associated with codon positions vs helix content of proteins Figure 17
Free folding energy associated with codon positions vs helix content of proteins. Linear regression analyses; pink symbols represent the 
linear regression line.
Free folding energies associated with codon residues (Free folding energies (FFE) were determined in phase-selected subse- quences of 81 different protein protein-encoding nucleic acids Figure 16
Free folding energies associated with codon residues (Free folding energies (FFE) were determined in phase-selected subsequences of 81 
different protein protein-encoding nucleic acids. The lines indicate individual values (left part of the figure), while the bars (right part of 
the figure) indicate the mean ± SEM (n = 81).Theoretical Biology and Medical Modelling 2007, 4:45 http://www.tbiomed.com/content/4/1/45
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stranded sequences is reversed and (partially) comple-
mented (Figure 22).
Comparison of the protein and mRNA secondary 
structures
The partial (suboptimal) reverse complementarity of
codon-related positions in nucleic acids suggested some
similarity between protein structures and the possible
structures of the coding sequences. This suggestion was
examined by visual comparison of 16 randomly selected
protein residue contact maps and the energy dot-plots of
the corresponding RNAs. We could see similarities
between the two different kinds of maps (Figure 23).
However, this type of comparison is not quantitative and
statistical evaluation is not directly possible.
Another similar, but still not quantitative, comparison of
protein and coding structures was performed on four pro-
teins that are known to have very similar 3D structures but
their primary structures (sequences) and the sequences of
their mRNAs are less than 30% similar. These four pro-
teins exemplify the fact that the tertiary structures are
much more conserved than amino acid sequences. We
asked whether this is also true for the RNA structures and
sequences. We found that there are signs of conservation
of the RNA secondary structure (as indicated by the energy
dot-plots) and there are similarities between the protein
and nucleic acid structures (Figure 24).
The similarity between mRNA and the encoded protein
secondary structures is an unexpected, novel observation.
The 21/64 redundancy of the genetic code gives a 441/
4.096 codon pair redundancy for every amino acid pair. It
means that every amino acid pair might be coded by ~9
different codon pairs (some are complementary but most
are not). The similarity between protein and correspond-
ing mRNA structures indicates extensive complementary
coding of co-locating amino acids. The possible number
of codon variations and possible nucleic acid structures
behind a protein sequence and structure is very large (Fig-
ure 25) and the same applies to the corresponding folding
energies (dG, the stability of the mRNA).
Complementary codes vs amino acid co-locations
Comparisons of the protein residue contact map with the
nucleic acid folding maps suggest similarities between the
3D structures of these different kinds of molecules. How-
ever, this is a semi-quantitative method.
More direct statistical support might be obtained by ana-
lyzing and comparing residue co-locations in these struc-
tures. Assume that the structural unit of mRNA is a tri-
nucleotide (codon) and the structural unit of the protein
is the amino acid. The codon may form a secondary struc-
ture by interacting with other codons according to the W-
C base complementary rules, and contribute to the forma-
tion of a local double helix. The 5'-A1U2G3-3' sequence
(Met, M codon) forms a perfect double string with the 3'-
U3A2C1-5' sequence (His, H codon, reverse and comple-
mentary reading). Suboptimal complexes are 5'-A1X2G3-
3' partially complemented by 3'-U3X2C1-5' (AAG, Lys;
AUG, Met; AGG, Arg; ACG, Pro; and CAU, His; CUU, Leu;
CGU, Arg; CCU, Pro, respectively).
Our experiments with FFE indicate that local nucleic acid
structures are formed under this suboptimal condition,
i.e., when the 1st and 3rd codon residues are complemen-
tary but the 2nd is not. If this is the case, and there is a con-
nection between nucleic acid and protein 3D structures,
one might expect that the 4 amino acids encoded by 5'-
A1X2G3-3' codons will preferentially co-locate with the 4
FFE associated with codon positions vs protein structure Figure 18
FFE associated with codon positions vs protein structure. Same 
data as in Figure 17 after calculating ratios and log transformation. 
Linear regression analyses; pink symbols represent the linear 
regression line.Theoretical Biology and Medical Modelling 2007, 4:45 http://www.tbiomed.com/content/4/1/45
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different amino acids encoded by 3'-U3X2C1-5' codons.
We constructed 8 different complementary codon combi-
nations and found that the codons of co-locating amino
acids are often complementary at the 1st and 3rd posi-
tions and follow the D-1X3/RC-3X1 formula but not the
other seven formulae (Figures 26 and 27).
These special amino acid pairs and their frequencies are
indicated and summarized in a matrix (Figure 28).
It is well known that coding and non-coding DNA
sequences (exon/intron) are different and this difference
is somehow related to the asymmetry of the codons, i.e.,
that the third codon letter (wobble) is poorly defined.
Many Markov models have been formulated to find this
Correlation between alpha helix content of protein structure and other protein characteristics Figure 19
Correlation between alpha helix content of protein structure and other protein characteristics. The alpha helix content of 80 protein 
structures was compared to the frequency of other major structural elements (A,B), the frequency of individual amino acids (C) and the 
frequency of charged and hydrophobic residues (D,E). (A) The correlation between helix (H), beta sheet (S) and turn (T); (B) the propor-
tions between the sum of helices (SH), beta strands (SS), turns (ST) and all other structural elements (TO). (D) The proportion between 
the sums of apolar (S_Ap), polar (S_Pol), negatively charged (S_Neg) and positively charged (S_Poz) amino acids. (E) The linear regression 
analysis correlations between helix content and the percentages of polar+apolar (Polarity) and positively+negatively charged (Charge) 
residues.Theoretical Biology and Medical Modelling 2007, 4:45 http://www.tbiomed.com/content/4/1/45
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asymmetry and predict coding sequences (genes) de novo.
These in silico methods work rather well but not perfectly
and some scientists remain unconvinced that codon
asymmetry explains the exon-intron differences satisfacto-
rily.
Another codon-related problem is that the well-known,
non-overlapping triplet codon translation is extremely
phase-dependent and there is theoretically no tolerance of
any phase shift. There are famous examples of how a sin-
gle nucleotide deletion might destroy the meaningful
translation of a sequence and are incompatible with life.
However, considering the magnitude and complexity of
the eukaryotic proteome, the precision of translation is
astonishingly good. Such physical precision is not possi-
ble without a massive and consistent physico-chemical
basis. Therefore, discovery of the existence of secondary
structure bias (folding energy differences) in coding
regions of many organisms [77] was a very welcome
observation because it differentiates exons from introns
physico-chemically.
Our experiments with free folding energy (FFE) confirmed
that this bias exists. In addition, there is a very consistent
and very significant pattern of FFE distribution along the
nucleotide sequence. Comparing the FFE of phase-
selected subsequences, subsequences comprising only the
1st or only the 3rd codon letters showed significantly
higher FFE than those consisting only of the 2nd letters.
This FFE difference was not present in intronic sequences
Location of free folding energy in codons Figure 21
Location of free folding energy in codons. Free folding energies (FFE) were determined in phase-selected subsequences of 31 different 
protein-coding nucleic acids. The original intact RNA contained the intact three-letter codons (123). Subsequences were constructed by 
periodical removal of one letter from the codon while maintaining the other two (12, 13, 23) or removing two letters and maintaining 
only one (1, 2, 3). The lines indicate individual values (left), while the bars (right) indicate the mean ± SEM (n = 31).
Correlation between frequency of individual amino acids and the main secondary structure elements in proteins Figure 20
Correlation between frequency of individual amino acids and the main secondary structure elements in proteins. See text for explanation.Theoretical Biology and Medical Modelling 2007, 4:45 http://www.tbiomed.com/content/4/1/45
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preceding and following the exons, but it was present in
exons from different species including viruses. This is an
interesting observation because this phenomenon might
not only distinguish between exons and introns on a
physico-chemical basis, but might also clearly define the
tri-nucleotide codons and thus the phase of the transla-
tion. This codon-related phase-specific variation in FFE
may explain why mRNAs have greater negative free fold-
ing energies than shuffled or codon choice randomized
sequences [84].
Free folding energy in nucleic acids is always associated
with W-C base pair formation. Higher FFE indicates more
W-C pairs (presence of complementarity) and lower FFE
indicates fewer W-C pairs (less complementarity). The FFE
in the 1st and 3rd codon positions was additive, while the
2nd letter did not contribute to the total FFE; the total FFE
of the entire (intact) nucleic acid was the same as subse-
quences containing only the 1st and 3rd codon letters
(2nd deleted). This is an indication that the local RNA sec-
ondary structure bias is caused by complementarity of the
1st and 3rd codon residues in local sequences. This par-
tial, local complementarity is more optimal in reverse ori-
entation of the local sequences, as expected with loop
formation.
It is known that single stranded RNA molecules can form
local secondary structures through the interactions of
complementary segments. The novel observation here is
that these interactions preferentially involve the 1st and
3rd codon residues. This connection between RNA sec-
ondary structure and codons immediately directed atten-
tion towards the question of protein folding and its long-
suspected connection to RNA folding [85,86].
Only about one-third (20/64) of the genetic code is used
for protein coding, i.e., there is a great excess of informa-
tion in the mRNA. At the same time, the information car-
ried by amino acids seems to be insufficient (according to
some scientists) to complete unambiguous protein fold-
ing. Therefore, it is believed that the third codon residue
(wobble base) carries some additional information to that
already present in the genetic code. A specialized wobble
base-oriented database, the ISSD [83], was established in
an effort to connect different features of protein structure
to wobble bases [87] more or less successfully.
We found a significant negative correlation between FFE
of the 2nd codon residue and the helix content of protein
structures, which was not expected even though this pos-
sibility is mentioned in the literature [73]. Our previous
work on a Common Periodic Table of Codons and
Nucleic Acids [52] indicated that the second codon resi-
due is intimately coupled with the known physico-chem-
ical properties of the amino acids. Almost all amino acids
show significant positive or negative correlation to the
helix content of proteins. Therefore, the real biological
meaning and significance of any connection between the
FFE of the 2nd codon residue and the propensity towards
a protein structural element is highly questionable.
A working hypotheses grew out of these observations,
namely that (a) partial, local reverse complementarity
exists in nucleic acids and forms the nucleic acid structure;
(b) there is some degree of similarity between the folding
of nucleic acids and proteins; (c) nucleic acid structure
determines the amino acid co-locations; (d) as a conse-
quence, amino acids encoded by the interacting (partially
reverse complementary) codons might show preferential
co-locations in the protein structures.
Nucleotide ratios in codons Figure 22
Nucleotide ratios in codons. The number of the 4 different nucle-
otide bases was counted at the 1st, 2nd and 3rd codon positions 
in 30 different protein coding RNA sequences. The ratios of the 
Watson-Crick pairs at different codon positions are indicated by 
bars (± SEM, n = 30). Ideally, the ratio of complementary base 
pairs is ~1.0. This ideal situation was mostly satisfied when one of 
the complementary bases was located at codon position 1 with 
the other at codon position 3 (pink) or both complements at 
codon position 2 (violet).Theoretical Biology and Medical Modelling 2007, 4:45 http://www.tbiomed.com/content/4/1/45
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This seems to be the case: codons that contain comple-
mentary bases at the 1st and 3rd positions and are trans-
lated in reverse orientation result in amino acids that are
preferentially co-located (interacting) in the 3D protein
structure. Other complementary residue combinations or
translation in the same (not reverse) direction (as much as
seven combinations in total) did not result in any prefer-
entially co-locating subset of amino acid pairs.
Construction of residue contact maps for protein struc-
tures and statistical evaluation of residue co-locations is a
frequently used method for visualizing and analyzing spa-
tial connections between amino acids [88-90]. The amino
acid co-locations in real protein structures are clearly not
random [91,92] and therefore residue co-location matri-
ces are often used to assist in the prediction of novel pro-
tein structures [93,94]. We have carefully examined the
Comparison of protein and corresponding mRNA structures (modified from [95]) Figure 23
Comparison of protein and corresponding mRNA structures (modified from [95]). Residue contact maps (RCM) were obtained from the 
PBD files of protein structures using the SeqX tool (left triangles). Energy dot-plots (EDP) for the coding sequences were obtained using 
the mfold tool (right triangles). The two kinds of maps were aligned along a common left diagonal axis to facilitate visual comparison of 
the different kinds of representation possible. The black dots in the RCMs indicate amino acids that are within 6 A of each other in the 
protein structure. The colored (grass-like) areas in the EDPs indicate the energetically mostly likely RNA interactions (color code in 
increasing order: yellow, green red, black).Theoretical Biology and Medical Modelling 2007, 4:45 http://www.tbiomed.com/content/4/1/45
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Comparison of the protein and mRNA secondary structures (modified from [95]) Figure 24
Comparison of the protein and mRNA secondary structures (modified from [95]). Residue contact maps (RCM) were obtained from the 
PBD files of 4 protein structures (1CBI, 1EIO, 1IFC, 1OPA) using the SeqX tool (left column). Energy dot-plots (EDP) for the coding 
sequences were obtained using the mfold tool (right column). The left diagonal portion of these two kinds of maps was compared in the 
central part of the figure. Blue horizontal lines in the background correspond to the main amino acid co-location sites in the RCM. Intact 
RNA (123) and subsequences containing only the 1st and 3rd codon letters (13) are compared. The black dots in the RCMs indicate 
amino acids that are within 6 A of each other in the protein structure. The colored (grass-like) areas in the EDPs indicate the energeti-
cally most likely RNA interactions (color code in increasing order: yellow, green red, black).Theoretical Biology and Medical Modelling 2007, 4:45 http://www.tbiomed.com/content/4/1/45
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physico-chemical properties of specifically interacting
amino acids in and between protein structures, and we
concluded that these interactions follow the well-known
physico-chemical rules of size, charge and hydrophobe
compatibility (unpublished data), well in line with Anfin-
sen's prediction. A recent study supports the view that
there is a previously unknown connection between the
codons of specifically interacting amino acids; those
codons are complementary at the 1st and 3rd (but not the
2nd) codon positions.
The idea that sequence complementarity might explain
the nature of specific protein-protein interactions is not
new and was suggested as early as 1981 [9-11].
Independence of sequence and structure of a protein and its mRNA Figure 25
Independence of sequence and structure of a protein and its mRNA. The amino acids in a U-shaped protein structure are encoded by 
complementary codons (rule PC1). The nucleic acid structure is uniform and the folding energy is -132 kcal/mol. Exactly the same amino 
acid sequence might be encoded by non- or only partially complementary codons, which will fundamentally alter the mRNA structure and 
increase the folding energy to -31 kcal/mol (less stable). The nucleic acid structures were generated by mfold and dGs were calculated by 
the same program.Theoretical Biology and Medical Modelling 2007, 4:45 http://www.tbiomed.com/content/4/1/45
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I was never able to confirm my own original theory(per-
fect complementarity between codons of interacting
amino acids [9-11,50] experimentally, in contrast to oth-
ers [37]. The explanation is that this codon complementa-
rity is suboptimal and does not involve the 2nd codon
residue. Experimental in vitro confirmation is required to
validate this recent theoretical and in silico prediction.
Theory of nucleic acid (chaperon)-assisted protein folding
So far, a series of novel arguments has been presented to
support a deeper connection than the traditional codon
translation between nucleic acids and expressed proteins.
The physico-chemical properties of amino acids are
clearly associated with the 2nd codon letter as shown in
the Common Periodic Table of Codons and Amino Acids.
The co-locating amino acids are preferentially encoded by
codons that are complementary at the 1st and 3rd posi-
tions. The structures of proteins and their encoding
nucleic acids are rather similar to each other in many
cases. All these observations suggest the co-evolution of
codons and amino acids and that protein folding (struc-
tural) information is present in the nucleic acids in addi-
Complementary codes vs amino acid co-locations (modified from [95]) Figure 26
Complementary codes vs amino acid co-locations (modified from [95]). The propensities for the 400 possible amino acid pairs were 
monitored in 81 different protein structures with the SeqX tool. The tool detected co-locations when two amino acids were within 6 A 
of each other (neighbors on the same strand were excluded). The total number of co-locations was 34,630. Eight different complemen-
tary codes were constructed for the codons (2 optimal and 6 suboptimal). In the two optimal codes, all three codon residues (123) were 
complementary (C) or reverse complementary (RC) to each other. In the suboptimal codes, only two of three codon residues were C or 
RC to each other (12, 13, 23), while the third was not necessarily complementary (X). (For example, Complementary Code RC_1X3 
means that the first and third codon letters are always complementary, but the not the second, and the possible codons are read in 
reverse orientation. The 400 co-locations were divided into 20 subgroups corresponding to 20 amino acids (one of the co-locating pairs), 
each group containing the 20 amino acids (corresponding to the other amino acid in the co-locating pair). If the codons of the amino acid 
pairs followed the predefined complementary code the co-location was regarded as positive (P); if not, the co-location was regarded as 
negative (N). Each symbol represents the mean frequency of P or N co-locations corresponding to the indicated amino acid. Paired Stu-
dent's t-test, n = 20.Theoretical Biology and Medical Modelling 2007, 4:45 http://www.tbiomed.com/content/4/1/45
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tion to the canonical genetic code. This immediately raises
the possibility of nucleic acid-assisted protein folding, i.e.
the possibility of nucleic acid chaperons [95]. This is an
exciting possibility, because the protein primary sequence
seems not to carry all the necessary information for unam-
biguous protein folding (in conflict with Anfinsen's theo-
rem), while there is a twofold excess of information in the
redundant genetic code. A theoretical example of how
such nucleic acid-assisted protein folding may look is pre-
sented in Figures 29 and 30.
Definition of the 2nd generation Proteomic 
Code
The Proteomic Code is a set of comprehensive rules by
which information in genetic material is transferred into
the physico-chemical properties of amino acids and deter-
mines how individual amino acids interact with each
other during protein folding and in specific protein-pro-
tein interactions. The Proteomic Code is part of the redun-
dant genetic code. The theory of Proteomic Code contains
the following observations:
- Co-locating (interacting) amino acids in native proteins
are encoded by partially (imperfect) complementary
codons in reverse (5'→3'/5'→3') orientation.
- Partial complementarity means that the 1st and 3rd
codon bases are complementary (Watson-Crick) bases to
each other, while the 2nd bases may or may not be com-
plementary to each other.
- The physico-chemical characteristics of the coded and
interacting amino acids are determined mainly by the 2nd
(central) codon residues.
- The physico-chemical properties of the interacting
amino acids (size, charge, and hydropathy) are compati-
ble with each other at the individual amino acid level.
- Nucleic acids (exons) contain protein folding informa-
tion within (or in addition to) the redundant genetic
code.
- Nucleic acids may directly assist protein folding as chap-
erons.
There are four different Proteomic Codes at this moment.
PC1_C and PC1_RC are the original codes based on the
perfect complementarity of all three codon bases in com-
plementary (C, 5'→3'/3'→5') readings; PC2_C and
PC2_RC are the recently extended codes requiring base
pair complementarity at the 1st and 3rd codon positions
but not necessarily at the 2nd. PC1 is part of PC2. The
PC_C variants require 3'→5' translations, which do not
exist, therefore I regard this variant as an artifact, caused
by the symmetry of many codons. Only a small percent-
age codon and amino acid pairs belongs to PC1; ~50% of
all amino acid pairs and >60% of all codon pairs can be
classified into PC2_RC (Figures 31 and 32).
All possible amino acid pairs (21 × 21 = 441, including
the virtual pairs formed with the Stop/End signal), are
listed in a Table [see Additional file 2]. The most impor-
tant physico-chemical parameters (molecular weight
(MW), isoelectric point (pI), hydropathy (HP)) and the
derived values of three compatibility indexes (charge
(CCI), size (SCI) and hydropathy (HCI) compatibility
indices [58]) as well as the expected frequency of the
amino acid pairs (natural frequency (NF), calculated from
codon table 1) are included in Table 4. P (positive) and N
(negative) indicate whether an amino acid pair may or
may not be coded by a given Proteomic Code.
The Origin of Proteomic Code as part of the Genetic Code
The theory of Ikehara [reviewed in [96,97]] about the ori-
gins of gene, genetic code, protein and life is especially
interesting regarding the Proteomic Code. Ikehara sug-
gests (and support with experimental evidence) that gene-
protein system, comprised of 64 codons and 20 amino
acids developed successfully during the evolution.
The development started with a GNC-type primeval genetic
code (G: guanine, C: Cytosine, N: any of the four nucle-
Complementary codes vs amino acid co-locations (ratios)  (modified from [95]) Figure 27
Complementary codes vs amino acid co-locations (ratios) (modi-
fied from [95]). The ratio of positive (P) and negative (N) co-loca-
tions was calculated on data from Figure 13. Each bar represents 
the mean ± SEM (n = 20).Theoretical Biology and Medical Modelling 2007, 4:45 http://www.tbiomed.com/content/4/1/45
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otides), coding only four amino acids (Gly: [G], Ala: [A],
Asp: [D], Val: [V]) forming the so called [GADV]-proteins.
This minimal set of only four amino acids and the
[GADV]-proteins are able to represent the 6 major (and
characteristic) protein moieties/indices (hydropathy, a-
helix, b-sheet and b-turn forms, acidic amino acid content
and basic amino acid content) which are necessary for
appropriate three-dimensional structure formation of
globular, water-soluble proteins on the primitive earth.
The [GADV]-proteins (even randomized) have catalytic
properties and able to facilitate the syntheses of other
[GADV]-proteins (also random).
The primeval genetic code continued to develop toward a
more complex SNS-type primitive genetic code (S: G or C)
containing 16 codons and encoding 10 amino acids (L, P,
H, Q, R, V, A, D, E, G) before the recent 64 codon/20 amino
acid-type recent genetic code became established.
Furthermore, Ikehara concluded from the analysis of
microbial genes that newly-born genes are products of
nonstop frames (NSF) on antisense strands of microbial
GC-rich genes [GC-NSF(antisense)] and from SNS repeat-
ing sequences [(SNS)n] similar to the GC-NSF(antisense).
The similarity between GNC/SNS-type primitive codons
(which are expressed even from the reverse-complement
strands as GC-rich non-stop genes) and the Proteomic
Code is obvious. Both concepts suggest and agree with
each other regarding
a) the connection between 2nd codon residue and the fun-
damental physicochemical properties of the coded amino
acids,
b) the importance of 1st and 3rd codon letters in determin-
ing the nucleic acid (as well as protein) structure,
c) the importance of compositional difference between
1st, 3rd and central codon residues (to emphasize the
codon boundaries),
d) the importance of complementarity (even in the
mRNA) in development of protein structure and function,
Complementary codes vs amino acid co-locations Figure 28
Complementary codes vs amino acid co-locations. See text for explanation.Theoretical Biology and Medical Modelling 2007, 4:45 http://www.tbiomed.com/content/4/1/45
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e) the importance of GC at the 1st and 3rd codon positions
(as the source of lower Gibbs energy, than central codon
positions have, where even AT are permitted).
I think, that the concept of GNC/SNS-type primitive
codons and the Proteomic Code are convergent ideas,
both reflecting the same fundamental aspects of the con-
nection between nucleic acid and protein structure and
function.
System and method for obtaining oligo-peptides 
with specific high affinity for query proteins
I have developed a system and method for obtaining
oligo-peptides with specific high affinity for query pro-
teins [98]. The method is based on the second generation
Proteomic Code. Figures 33 and 34 show the steps in this
system for producing the target proteins with a high affin-
ity for query proteins; it is assumed the primary structures
of the query proteins are known.
There is no limitation to the size of the query; however,
the sequence is preferably in the range 5–40 amino acid
residues, and best in the range 7–15. Preferably, the real
and natural coding sequence is known for the query pro-
tein. However, there might be some special cases in which
the sequence is not exactly known, for example designed
or artificially modified proteins. Thus, it is possible to fab-
ricate a virtual coding sequence with back translation
using Codon Usage Frequency Tables. The present
method relies on the entire information carried by the
naturally-occurring DNA/mRNA and not only that used
for coding of the protein primary sequence.
The query sequence should be a "promising" domain of
the query protein and specific domains are more impor-
tant, including domains that: (a) are known to be anti-
genic; (b) are located on the surface of the query protein;
(c) are not simple (repetitive) sequences; (d) contain less
frequent amino acids; and (e) contain charged amino acid
residues.
Once the promising area of the known amino acid
sequence is chosen and the nucleotide sequence is deter-
mined, then construction of nucleic acid sequences
encoding the target proteins is initiated. The target nucle-
otide (RNA or DNA) prediction should follow a simple
rule, namely that the 1st and 3rd codon letters of the target
nucleotide sequences should be reverse-complementary
to the 1st and 3rd codon nucleotide residues of the query
nucleotide sequence, but the middle, 2nd residue can be
any of the four possible nucleotides. The expected number
of predicted target RNAs will be 4n, where n is the number
of amino acids (= number of codons, = number of 2nd
codon letters).
Nucleotide sequences can be produced readily, for exam-
ple, directly synthesizing the fragment by chemical
means, applying nucleic acid reproduction technology
such as PCR, or excision of selected DNA fragments from
recombinant plasmids containing appropriate inserts and
suitable restriction enzyme sites. However, synthesis of
predicted (max. 4n) sequences on a one by one basis does
not seem practical. Thus, a simple mass-production
method is needed that will result in a mixture containing
all possible sequences in the predicted RNA/DNA pool.
Fortunately, the regular nature of the nucleotides in the
pool makes it possible to synthesize the entire pool of
sequences as if it were only one single nucleotide
sequence. For example, the usual step-by-step (base by
base) protocol can be followed except at the positions for
the synthesis of the 2nd codon residue. At those points in
the synthesis process, an equal mixture of the four nucle-
otides should be provided instead of a single nucleotide.
The result of this modified oligo-nucleotide synthesis
should be a mixture of the desired potential target RNAs.
RNA-assisted protein loop formation (from [95]) Figure 29
RNA-assisted protein loop formation (from [95]). Translation 
begins with the attachment of the 5' end of a mRNA to the ribos-
ome (A). Ribonucleotides are indicated by blue "+" and the 1st 
and 3rd bases in the codons by blue lines; the 2nd base positions 
are left empty. A positively charged amino acid ((+) and red dots), 
for example arginine, remains attached to its codon. The mRNA 
forms a loop because the 1st and 3rd bases are locally comple-
mentary to each other in reverse orientation (B). The growing 
protein is indicated by red circles. When translation proceeds to 
an amino acid with especially high affinity for the mRNA-attached 
arginine, for example a negatively charged Glu or Asp ((-) and blue 
dot), the charge attraction removes the Arg from its mRNA bind-
ing site and the entire protein is released from the mRNA and 
completes a protein loop (C). The protein continues to grow 
towards the direction of its carboxy terminal (COOH).Theoretical Biology and Medical Modelling 2007, 4:45 http://www.tbiomed.com/content/4/1/45
Page 32 of 44
(page number not for citation purposes)
The predicted and synthesized RNAs in the pool are
cloned by the standard procedure, which involves inser-
tion of RNA into vector (plasmid or other carrier) and
multiplying the sequences in bacteria or yeast as described
in the literature. Expression vectors of the system may
comprise polynucleotides operatively linked to an
enhancer-promoter such as a prokaryotic or eukaryotic
promoter. Further, an enhancer may be included in the
vector. A major function of an enhancer is to increase the
level of transcription of a coding sequence in a cell that
contains one or more transcription factors that bind to
that enhancer. Unlike a promoter, an enhancer can func-
tion when located at variable distances from transcription
start sites so long as a promoter is present.
Expression vectors of the present system comprise polynu-
cleotides that encode the target peptides of the pool.
Where expression of recombinant polypeptide is desired
and a eukaryotic host is contemplated, it is best to employ
a vector such as a plasmid that incorporates a eukaryotic
origin of replication. In addition, for the purposes of
expression in eukaryotic systems, it is desired to position
the peptide-encoding sequence adjacent to and under the
control of an effective eukaryotic promoter such as those
used in combination with Chinese hamster ovary cells. To
bring a coding sequence under the control of a promoter,
whether it is eukaryotic or prokaryotic, what is generally
needed is to position the 5' end of the translation initia-
tion side of the proper translational reading frame of the
RNA-assisted (translational) protein folding (from [95] Figure 30
RNA-assisted (translational) protein folding (from [95]. There are three reverse and complementary regions in a mRNA (blue line, A): a-
a', b-b', c-c', which fold the mRNA into a T-like shape. During the translation process the mRNA unfolds on the surface of the ribosome, 
but subsequently refolds, accompanied by its translated and lengthening peptide (red dotted line, B-F). The result of translation is a tem-
porary ribonucleotide complex, which dissociates into two T-shape-like structures: the original mRNA and the properly folded protein 
product (G). The red circles indicate the specific, temporary attachment points between the RNA and protein (for example a basic amino 
acid); the blue circles indicate amino acids with exceptionally high affinity for the attachment points (e.g., acidic amino acids); these cap-
ture the amino acids at the attachment point and dissociate the ribonucleoprotein complex. Transfer RNAs are of course important par-
ticipants in translation, but they are not included in this scenario.Theoretical Biology and Medical Modelling 2007, 4:45 http://www.tbiomed.com/content/4/1/45
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polypeptide between about 1 and 50 nucleotides 3' of (or
downstream with respect to) the promoter chosen. Fur-
thermore, where eukaryotic expression is anticipated, one
would typically desire to incorporate an appropriate poly-
adenylation site into the transcriptional unit that includes
the different target peptides.
pRc/CMV (available from Invitrogen) is an exemplary vec-
tor for expressing a peptide in mammalian cells, particu-
larly COS and CHO cells. Target polypeptides of the
present invention under the control of a CMV promoter
can be efficiently expressed in mammalian cells. The
pCMV plasmids are a series of mammalian expression
vectors of particular utility in the present system. The vec-
tors are designed for use in essentially all cultured cells
and work extremely well in SV40-transformed simian
COS cell lines. The pCMV1, 2, 3 and 5 vectors differ from
each other in certain unique restriction sites in the
polylinker region of each plasmid. The pCMV4 vector dif-
fers from these 4 plasmids in containing a translation
enhancer in the sequence prior to the polylinker. While
they are not directly derived from the pCMV1-5 series of
vectors, the functionally similar pCMV6b and c vectors,
available from the Chiron Corp. (Emeryville, CA), are
identical except for the orientation of the polylinker
region, which is reversed in one relative to the other. The
pCMV vectors have been successfully expressed in simian
COS cells, mouse L cells, CHO cells and HeLa cells.
Means of transforming or transfecting cells with exoge-
nous polynucleotide such as the nucleotide molecules of
the present system are well known and include techniques
such as calcium-phosphate- or DEAE-dextran-mediated
transfection, protoplast fusion, electroporation, lipo-
some-mediated transfection, direct microinjection and
adenovirus infection. The most widely-used method is
transfection mediated by either calcium phosphate or
DEAE-dextran. Although the mechanism remains
obscure, it is believed that the transfected DNA enters the
cytoplasm by endocytosis and is transported to the
nucleus. Depending on the cell type, up to 90% of a pop-
ulation of cultured cells can be transfected at any one
time. Because of its high efficiency, transfection mediated
by calcium phosphate or DEAE-dextran is the method of
choice for experiments that require transient expression of
the foreign DNA in large numbers of cells. Calcium phos-
phate-mediated transfection is also used to establish cell
lines that integrate copies of the foreign DNA, which are
usually arranged in head-to-tail tandem arrays into the
host cell genome.
The application of brief, high-voltage electric pulses to a
variety of mammalian and plant cells leads to the forma-
Propensity for PC-compatible amino acid pairs Figure 32
Propensity for PC-compatible amino acid pairs. There are 441 
possible amino acid pairs altogether (21 × 21, including the stop 
place as the 21st variable). Amino acids that are (P) or are not (N) 
coded by a specific complementary rule (Proteomic Code, PC) 
were counted. PC1 and PC2 indicate complementarity of the 
respective codon pairs at all 3 or only the first and third codon 
bases in parallel (C) or anti-parallel (RC) readings.
Propensity for PC-compatible codon pairs Figure 31
Propensity for PC-compatible codon pairs. There are 4096 possi-
ble codon pairs altogether (64 × 64, including those formed with 
the 3 stop codons). Codons that are (P) or are not (N) coded by a 
specific complementary rule (PC) were counted. The bars repre-
sent the mean ± SD of 9 independent determinations (n = 9). PC1 
and PC2 indicate complementarity of all 3 or only the first and 
third codon bases in parallel (C) or anti-parallel (RC) readings.Theoretical Biology and Medical Modelling 2007, 4:45 http://www.tbiomed.com/content/4/1/45
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tion of nanometer-sized pores in the plasma membrane.
DNA is taken directly into the cytoplasm either through
these pores or as a consequence of the redistribution of
membrane components that accompanies closure of the
pores. Electroporation can be extremely efficient and can
be used both for transient expression of cloned genes and
for establishment of cell lines that carry integrated copies
of the gene of interest. Electroporation, in contrast to cal-
cium phosphate-mediated transfection and protoplast
fusion, frequently gives rise to cell lines that carry one, or
at most a few, integrated copies of the foreign DNA.
Liposome transfection involves encapsulation of DNA or
RNA within liposomes, followed by fusion of the lipo-
somes with the cell membrane. The mechanism by which
DNA or RNA is delivered into the cell is unclear but trans-
fection efficiencies can be as high as 90%.
Direct microinjection of a DNA molecule into the nucleus
has the advantage of not exposing DNA to cellular com-
partments such as low pH endosomes. Microinjection is
therefore used primarily as a method for establishing lines
of cells that carry integrated copies of the DNA of interest.
A transfected cell can be prokaryotic or eukaryotic.
In addition to prokaryotes, eukaryotic microbes such as
yeast can also be used. Saccharomyces cerevisiae is the most
commonly used eukaryotic microorganism, although a
number of other strains are also available. For expression
Steps constituting the novel method for obtaining oligo-pep- tides with specific high affinity for query proteins Figure 34
Steps constituting the novel method for obtaining oligo-peptides 
with specific high affinity for query proteins.
Design and production of specifically interacting proteins (see text for details) Figure 33
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in Saccharomyces, the plasmid YRp7, for example, is com-
monly used. This plasmid already contains the trpl gene,
which provides a selection marker for a mutant strain of
yeast lacking the ability to grow in tryptophan, for exam-
ple ATCC No. 44076 or PEP4-1. The presence of the trpl
lesion as a characteristic of the yeast host cell genome then
provides an effective environment for detecting transfor-
mation by growth in the absence of tryptophan. Suitable
promoter sequences in yeast vectors include the promot-
ers for 3-phosphoglycerate kinase or other glycolytic
enzymes such as enolase, glyceraldehyde-3-phosphate
dehydrogenase, hexokinase, pyruvate decarboxylase,
phosphofructokinase, glucose-6-phosphate isomerase, 3-
phosphoglycerate mutase, pyruvate kinase, triosephos-
phate isomerase, phosphoglucose isomerase and glucoki-
nase. In constructing suitable expression plasmids, the
termination sequences associated with these genes are
also introduced into the expression vector downstream
from the sequences to be expressed to provide polyade-
nylation of the mRNA and termination. Other promoters,
which have the additional advantage of transcription con-
trolled by growth conditions, are those for alcohol dehy-
drogenase 2, isocytochrome c, acid phosphatase,
degradative enzymes associated with nitrogen metabo-
lism, the aforementioned glyceraldehyde-3-phosphate
dehydrogenase, and enzymes responsible for maltose and
galactose utilization. Any plasmid vector containing a
yeast-compatible promoter, origin or replication and ter-
mination sequences is suitable.
In addition to microorganisms, cultures of cells derived
from multicellular organisms can also be used as hosts. In
principle, any such cell culture is workable, whether from
vertebrate or invertebrate culture. However, interest has
been greatest in vertebrate cells, and propagation of verte-
brate cells in culture (tissue culture) has become a routine
procedure in recent years. Examples of such useful host
cell lines are AtT-20, VERO and HeLa cells, Chinese ham-
ster ovary (CHO), and W138, BHK, COSM6, COS-1, COS-
7, 293 and MDCK. Expression vectors for such cells ordi-
narily include (if necessary) an origin of replication, a pro-
moter located upstream of the gene to be expressed, along
with any necessary ribosome binding sites, RNA splice
sites, polyadenylation site, and transcriptional terminator
sequences.
For use in mammalian cells, the control functions on the
expression vectors are often derived from viral material.
For example, commonly used promoters are derived from
polyoma, Adenovirus 2, Cytomegalovirus and most fre-
quently Simian Virus 40 (SV40). The early and late pro-
moters of SV40 are particularly useful because both are
obtained easily from the virus as a fragment that also con-
tains the SV40 origin of replication. Smaller or larger SV40
fragments can also be used, provided they include the
approximately 250 bp sequence extending from the Hin-
dIII site towards the BglI site located in the viral origin of
replication. It is also possible, and often desirable, to uti-
lize promoter or control sequences normally associated
with the desired gene sequence, provided such control
sequences are compatible with the host cell systems.
Culture conditions are well known and include ionic
composition and concentration, temperature, pH, etc.
Typically, transfected cells are maintained under culture
conditions; suitable media for various cell types are well
known. Temperature is preferably from about 20°C to
about 50°C. pH is preferably from about 6.0 to about 8.0,
better in the range 6.8–7.8 and best at about 7.4. Other
biological conditions needed for transfection and expres-
sion of an encoded protein are well known.
Following transfection, the cell is maintained under cul-
ture conditions for a period of time sufficient for the target
proteins of the pool to be expressed. A suitable time
depends inter alia upon the cell type used and is readily
determinable by a skilled technician. Typically, mainte-
nance time is from about 2 to 14 days. Recovery of the tar-
get proteins comprises isolating and purifying the
recombinant polypeptides. Isolation and purification
techniques for polypeptides are well known and include
such procedures as precipitation, filtration, chromatogra-
phy, electrophoresis, etc.
The target proteins are preferably arranged in a library
assay system for screening with samples of the query pro-
tein. Any method that detects specific, high affinity pro-
tein-protein interactions is theoretically useful for
screening.
Selecting the best clones, with the proteins interacting
most specifically and with highest affinity, can be fol-
lowed by repeated screenings, thus leading to the most
desired target proteins with the highest binding affinity
for the query protein. These are suitable for large-scale tar-
get protein production.
These aspects and embodiments of the present system are
further described in the following examples. However, the
present system is not limited by such examples, and vari-
ations will be apparent to those skilled in the art without
departing from the scope of the present setup.
Example 1
Figure 35 shows the use of the present system to obtain a
specific high affinity protein with binding affinity for a
section of the A-peptide in human insulin.
Starting with the known protein and nucleic acid
sequences of the entire Pre-pro-insulin, 1–10 residues ofTheoretical Biology and Medical Modelling 2007, 4:45 http://www.tbiomed.com/content/4/1/45
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Representative query amino acid sequences and preparation of reverse and complementary sequences, the second nucleotide  of each codon in which is replaced with a variable X nucleotide Figure 35
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the A peptide and the corresponding nucleic acid
sequence are selected. The selected part of the peptide,
called the query, is used to screen the target protein
expression library. Therefore, this sequence should be
available in pure peptide form.
Next, a sequence is created that is complementary to the
query nucleotide sequence at the 1st and 3rd codon posi-
tions but leaving the 2nd position undefined (X). The
complementary sequence is reversed and, in this particu-
lar example, the bases T are changed to U. The second
(central) codon position remains undefined and this
undefined X position can be any one of the possible
nucleotides (A, U, G, C). Therefore, this prediction
method defines many different target RNA sequences. In
the case of a sequence including 30 nucleotide bases, the
expected number of possible target sequences will be
about 410 = 106.
The predicted pool of target RNAs is synthesized by fol-
lowing the usual step-by-step (base by base) protocol,
known to those skilled in the art, except the syntheses of
the X positions. At the X position, a mixture of nucleotide
bases is provided (which contain equal amounts of A and
U and G and C). The result of this modified oligo-nucle-
otide synthesis is a mixture of the desired potential target
RNAs as shown in Figure 36. The target RNAs are cloned
and transfected via an expression vector into a cell for
expression of the encoded protein. An expression library
of the expressed target protein is created for screening for
query protein/target protein affinity binding. When bind-
ing complexes are found to meet the affinity binding lev-
els, the target protein may be cloned for large-scale
production.
These steps may be repeated numerous times by modify-
ing the length of the query sequence and/or using another
domain area of the query protein that may be of interest.
Example 2. Example of design and characterization of a 
specific protein-protein interaction
The BacterioMatch™ two-hybrid system (Stratagene,
11011 N. Torrey Pines Road, La Jolla, CA 92037) was used
for quick detection of protein-protein interactions
designed by the recent method. It is a simple alternative or
complement to yeast two-hybrid systems for detection of
such interactions in vivo. Because the two-hybrid assay is
performed in bacteria, the results are obtained more easily
and quickly than in yeast. The system is based on tran-
scriptional activation of a primary ampicillin-resistant
reporter and a secondary β-galactosidase reporter for vali-
dation. The BacterioMatch two-hybrid system is based on
a methodology developed by Dove, Joung, and Hoch-
schild of Harvard Medical School.
The BacterioMatch two-hybrid system is based on tran-
scriptional activation (Figure 37). A protein of interest –
the bait – is fused to the full-length bacteriophage repres-
sor protein (λcI). The corresponding target protein is
fused to the amino-terminal domain of the α-subunit of
RNA polymerase (RNAPα). The bait is tethered to the x
operator sequence upstream of the reporter promoter
through the DNA-binding domain of λcI. If the bait and
The BacterioMatch™ Figure 37
The BacterioMatch™. Two-hybrid system (reproduced from 
Strategene).
Synthesis pattern for construction of target sequences and  the progression of the permutations depending on the  number of amino acid residues Figure 36
Synthesis pattern for construction of target sequences and the 
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target interact, they recruit and stabilize the binding of
RNA polymerase close to the promoter and activate the
transcription of the ampicillin-resistant reporter gene in
the BacterioMatch two-hybrid reporter strain. The β-galac-
tosidase reporter gene provides an additional mechanism
for validating putative protein-protein interactions.
(a)  Bait vector. The bait vector, pBT, encodes the full-
length bacterial phage cI protein under the control of the
strong lacUV5 promoter. A protein of interest is fused to
the bacterial phage λcI protein by inserting its gene into
the multiple cloning site at the 3' end of the λcI gene. The
presence of a multiple cloning site makes it convenient to
subclone a bait gene that is already present in many yeast
two-hybrid bait plasmids.
(b) Target vector. The target plasmid, pTRG, is compatible
with Stratagene's cDNA library construction kit. The target
plasmid directs transcription of the amino-terminal
domain of RNA polymerase α-subunit and linker region
under the control of tandem promoters lpp and lacUV5.
The target gene is fused in-frame to the α-subunit NTD
through a multiple cloning site at the 3' end of the α-sub-
unit gene.
(c) Reporter strain. The reporter strain is derived from XL1-
Blue MRF'. The strain lacks all restriction systems in order
to be compatible with current cDNA library construction
methods. The lac Iq gene, located on the F' episome,
represses synthesis of the bait and target until induction.
The reporter cassette is also located on the F' episome in
the cell. The lacZ gene serves as a secondary reporter to
provide a visible phenotype for identifying positive pro-
tein-protein interactions.
Definitions
Query (or bait) is one protein sequence with which the tar-
get protein, designed and produced by the method, will
specifically interact. Target protein is one or more protein
sequence(s) designed by the method to interact specifi-
cally with the query protein sequence. The target is
expected to be present in a pool of protein sequences
called the target pool. The target pool is designed using a
target template, which is a nucleic acid sequence containing
2/3 defined and 1/3 undefined nucleotides (X). (A target
template, which contains 15 undefined nucleic acid resi-
dues, will result in 415 = 109 different oligonucleotides,
which will be translated into the corresponding number
of proteins.) The target pool is synthesized using a target
oligo template (TOT) which has a constant (C) and variable
(V) part. The TOT-C is necessary to synthesize dsDNA of
the target pool sequences and it is ~20 nucleotides long.
The TOT-V (target template) is about 30–45 nucleotides
long, 2/3rd of the nucleotides being unambiguously
defined while 1/3rd are not (X). The X residues should be
incorporated by adding a mixture of nucleotides (equal
amounts of A+T+G+C) to the reaction during oligo syn-
thesis.
The results (numbers of highly, moderately and slightly
positive clones) are evaluated by visual inspection. The
positive clones are saved for further experiments. If there
are no positive clones, it is necessary to validate the orien-
tation and translation frame in the target mRNAs. This is
possible by sequencing some target mRNAs. The sequence
should show the residue pattern.
Both TARGET TEMPLATE to ESRLERLEQLFLLIF (GAL4
09-23AA) and TARGET TEMPLATE to QLFLLIF-
PREDLDMI (GAL4 17-31AA) contained numerous posi-
tive bacterial clones growing on double selective medium.
Sequencing of DNA from the vectors in randomly selected
positive clones confirmed that:
- they contained the characteristic TOT pattern, i.e.
defined 1st and 3rd codon residues;
- the nucleic acids differed only in the 2nd codon posi-
tions; their 1st and 3rd codon positions were identical;
- The restriction endonuclease recognition sequences were
present;
- the start and stop codons were present;
- the sequences were inserted into the correct, sense DNA
strands;
- the codon frames were correct in relation to the start
codon and were read in the correct frames.
Some positive TARGET TEMPLATE to ESRLERLEQLFLLIF
(GAL4 09-23AA) clones were further processed to mono-
clonal colonies and proteins were extracted. Characteriza-
tion of the binding properties of fluorescently labeled
GAL4 peptide to the protein extract indicated the presence
of saturable binding sites in the protein extracts from pos-
itive clones and the absence of saturable binding sites in
the negative clones.
The experiment
The experiment below is specifically designed for the Bac-
terioMatch (Stratagene) two-hybrid system. This system
uses:
- a bait vector (pBT) and the manufacturer's standard as
insert, the dimerization domain of 1HBW REGULATORY
PROTEIN GAL4;Theoretical Biology and Medical Modelling 2007, 4:45 http://www.tbiomed.com/content/4/1/45
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- a target vector (pTRG) and the manufacturer's standard
as insert, and a ~90 aa long mutant form of Gal11.
In the experiment below the target oligo pool is used
instead of Gall1 in the pTRG vector.
The query in this experiment is the dimerization domain
of 1HBW REGULATORY PROTEIN GAL4 inserted into
pBT (as provided and described by Stratagene). The target
oligo templates (TOT-V) were designed to interact specif-
ically with K01486_SCGAL4_DIMDOM-171/9-23 and
K01486_SCGAL4_DIMDOM-171/17/31 sequences.
The sequences below are sense, ssDNA sequences, which
means that the TOT-V in this sequence is the same as the
sequence in the expected mRNAs (except for T/U conver-
sion). The TOT-C is not indicated here; BPD can decide
which TOT-C to use for this purpose (Figure 38).
The experiment consists of the following steps:
(1) Sequence the Gal 4 DNA (provided by Stratagene) to
make sure that the query sequence is as expected.
(2) Synthesize the target pool using the target oligo tem-
plates. This is a single run routine oligo synthesis. Residue
X is equal amounts of A+T+G+C.
(3) Make dsDNAs. This is a single run PCR.
(4) Make restriction enzyme cuts on the target oligo pool
sequences. This is a single run RE reaction.
(5) Insert the oligo pool sequences into the pTRG vector.
~109 different vectors are expected. Make sure that the ori-
entation of the target oligos is correct and the transcrip-
tion will result in the following mRNA. The target oligo
pool insertion is a single run ligase reaction (Figure 39).
Transcription of TOT dsDNA will result in TOT mRNA. A
45 nucleotide long TOT will be translated into 415 differ-
ent oligopeptides, each 15 amino acids long. Some of
these oligopeptides are expected to interact specifically
with the respective GAL4 targets.
(6) Insert the vectors into bacteria.
(7) Perform the BacterioMatch two-hybrid assay accord-
ingly to the Stratagene manual.
The Kd of the binding sites varied between 1 and 100 nM,
indicating the presence of a limited number of high affin-
ity binding sites. Unlabelled GAL4 inhibited the binding
of labeled GAL4 to the proteins from positive clones while
other randomly chosen proteins (insulin, growth hor-
mone, prolactin) were ineffective competitors even in
much higher concentrations.
This experiment indicates that it is possible to design spe-
cifically interacting oligo-peptides (target) to any oligo-
peptide (query) and detect the interaction in a bacterial
two-hybrid system (like BacterioMatch™. The method is
quick; it takes only a few days to obtain interacting mon-
oclonal proteins. The designed protein-protein interac-
tion is highly specific and has high affinity (Kd ~ 1–100
nM).
Further details can be found in the following references
[58,59,98].
The transcription of TOT dsDNA will result in TOT mRNA Figure 39
The transcription of TOT dsDNA will result in TOT mRNA. A 45 
nucleotide long TOT will be translated into 415 different oligopep-
tides, each 15 amino acids long. Some of these oligopeptides are 
expected to interact specifically with the respective GAL4 targets.
Sequences designed by this method were expected to pro- duce proteins (when transcribed and translated) with the  potential to interact specifically with the indicated domains of  the Gal4 protein Figure 38
Sequences designed by this method were expected to produce 
proteins (when transcribed and translated) with the potential to 
interact specifically with the indicated domains of the Gal4 pro-
tein. The 1st and 3rd codon letters in these target templates are 
complementary to the 3rd and 1st codon letters in the Gal4 cod-
ing sequences (reverse reading direction) while the 2nd codon let-
ter is undefined (A or T or G or C).Theoretical Biology and Medical Modelling 2007, 4:45 http://www.tbiomed.com/content/4/1/45
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SHARHs compared to other affinity reagent designs
Really  ab initio design of affinity peptides (antibodies,
receptors) is not yet possible, because the rules of specific
protein-protein interactions are not well understood.
Therefore random protein library constructions and affin-
ity screenings are used as alternative methods to the clas-
sical immunization techniques.
Affibodies (Affibody of Bromma in Sweden) were among
the first non-immunoglobulin-based affinity reagents.
These small molecules are based on a bacterial receptor
(Staphylococcus aureus protein A), and use combinatorial
protein engineering to introduce random mutations in
the affinity region. [99].
Another non-immunoglobulin-based affinity reagent that
is becoming more widely used is the aptamer. Made of
DNA, RNA or modified nucleic acids and typically 15–40
bases in length, aptamers have a stable tertiary structure
that permits protein binding through van der Waals
forces, hydrogen bonding and electrostatic interactions.
Early studies showed that aptamers can be highly specific
for target proteins, with the ability to distinguish between
related members of a protein family [100].
No one of the above mentioned methods is able to satisfy
the emerging need to produce affinity reagents at a truly
high-throughput scale. A typical random peptide library
has about a billion phage clones – enough to represent
most of the 418 possible 6-mers, but far too small to repre-
sent the 445 possible 15-mers. Therefore the definition of
1st and 3rd codons accordingly to the Proteomic Code is a
big help to overcome these size limitation. The proteomic
Code makes it possible to design and produce 15-mers in
typical libraries (415 ~ 109).
What about if the concept of the Proteomic Code is
wrong? The method to design and produce SHARP pep-
tides in partially random libraries remains still plausible.
The characteristics of amino acids are largely determined
by the base on the second codon position and the bases
on the second positions are undefined or randomly
selected when using the SHARP method.
Conclusion
The promises of the second generation Proteomic Code
Industrial applications
The second generation Proteomic Code and the method
for developing SHARP have potential advantages that are
not obvious in the recent antibody-developing methods:
- provide quick access to interacting peptides;
- provide direct and permanent access to monoclonal
sources for large-scale production;
- SHARP is small (MW <2000 Da) compared to antibodies
(155 kDa) or affibodies (which gives therapeutic and
manufacturing advantage), no need for humanization;
- might be the key to mass production of interactive oli-
gopeptides (similar to the on-demand synthesis of nucle-
otide oligos;
- a self-learning method; every single successful SHARP
can contribute to a more and more exact amino acid inter-
action table.
Scientific potential
The present system is a unique in silico method for iden-
tifying the binding proteins that interact most effectively
with reactive epitopes on a respective protein antigen. The
system has widespread applications and is beneficial to
biotechnology. It is useful, for example, in developing
drugs for treating viral diseases such as AIDS and influ-
enza, as well as diseases such as Alzheimer's disease and
bovine spongiform encephalopathy. In addition to medi-
cal research and drug development, this system has appli-
cations related to environmental health and public safety,
including for example the detection of bacteria, viruses,
toxins, etc. in air, water and food supplies.
By way of further specific examples, the present system has
applications in the following areas:
1. improving health care, by providing a new and easily
implemented approach to the development of diagnostic
kits and therapeutic drugs;
2. improving the environment, by providing new and eco-
nomic approaches for detecting environmental patho-
gens;
3. improving working conditions by providing economic
and effective ways of detecting environmental pathogens;
and
4. improving homeland security by providing rapid detec-
tion of known as well as new pathogens in air, water,
food, etc.
The vision of a proteome-sensor chip
Detection and measurement of proteins is a fundamental
procedure in life sciences. Many diagnostic procedures are
already based on this technique and many more will fol-
low:
- detection of hormones and enzymes for diagnosis of
organ failure;Theoretical Biology and Medical Modelling 2007, 4:45 http://www.tbiomed.com/content/4/1/45
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- detection of pathogen-derived antigens or antibody
responses for diagnosis of infections;
- detection of allergens for allergy diagnoses;
- tumor markers to detect and evaluate neoplasias.
Considering that the number of hormones, enzymes,
pathogens, and markers is very large, it is easy to recognize
that the demand for specifically interacting diagnostic
proteins is large. However, there are limitations to satis-
faction of the demand. It takes several weeks to develop
one antibody by traditional methods. Therefore it is not
cheap. The traditional one protein-one kit method is sim-
ply no longer feasible. Some kind of integration is neces-
sary. Development points to protein chips that permit the
simultaneous, parallel detection of hundreds or thou-
sands of protein signals and the computerized integrated
evaluation of the results. Chip-based protein detection
requires a large number of easy-to-produce, cheap, inter-
acting proteins.
The Proteomic Code-based method described here could
contribute significantly to the industrial production of
such interacting peptides.
The SHARP chip-based technology opens the way to the
real possibility of monitoring the proteome, i.e. obtaining
detailed information on the qualitative and quantitative
state of a large number of different proteins simultane-
ously, even including some information about the splic-
ing and configuration changes in individual proteins
(Figure 40).
The human genome contains 3 × 109 base pairs. About 2%
of this is located in about 30,000 genes that are expressed,
spliced into ~100,000 different proteins containing ~40
million amino acids. The 2× coverage of this size pro-
teome with 15-residue complementary sequences
requires 5 million different oligopeptides. (This is proba-
bly the upper estimate, because the proteome contains
many similar or identical domains.) Proteome monitor-
ing with proteomic chips is a huge challenge, which can
only be met if SHARP proteins become accessible in much
larger number and for a much lower price than is possible
today.
The vision of a new physiology
The receptor – ligand and antigen – antibody type or inter-
action has a fundamental role in the physiology of
humans and animals. Obviously, peptides that can inter-
act specifically with regulatory pathways have significant
potential for manipulating these pathways. Most drugs are
effective because of their interaction with regulatory path-
ways (e.g., GPCR or 7TM receptor systems). Therefore,
easy and inexpensive access to designed interacting pro-
teins will have an impact on further development of phys-
iological and pharmacological research and drug
discovery. Some kind of industrial-scale, standardized,
semi-automated physiological research is also desirable.
The traditional one-by-one approach is too slow and too
expensive for the complexity of life.
The vision of new protein-based therapeutic approaches
Proteins/peptides are underutilized in medical therapy.
Only insulin is used to treat a common disease (Type I
diabetes); a few other proteins are used to treat relatively
rare diseases such as growth hormone (GH) deficiency
and hemophilia. Veterinary use of GH (lean meat produc-
tion) or misuse in sports and cosmetology far exceeds its
medical indication. Protein therapy is expensive and
requires daily injections, which is not attractive to most
patients. Most pharmaceutical companies have accumu-
lated large bodies of knowledge (and patent bases) regard-
ing traditional, simple molecular drug design and
treatments, while their knowledge in proteomics is still
undergoing development. Simple molecule-based drugs
do not provide much specificity. Protein-based, highly
specific treatments are not too far off in the future and
easy access to biologically active proteinaceous substances
will facilitate physiological evaluation and medical appli-
cation of these more complex peptide molecules.
Protein monitoring by SHARPs Figure 40
Protein monitoring by SHARPs. Specific and high affinity reacting 
proteins (SHARPs, 1–7) are designed and produced against a pro-
tein. The protein has 3 domains (A, B, C) and two main conforma-
tions (I, II). Domain B is exposed on the surface in conformation I 
and that form is detected by SHARPs 3–5. Domain B is sand-
wiched between domains A and C in configuration II and there-
fore this form is detected by SHARPs 1–2 and 6–7. A 
concentration and configuration dependent response is detected 
by a slot corresponding to the protein by the SHARPs CHIP 
(dots).Theoretical Biology and Medical Modelling 2007, 4:45 http://www.tbiomed.com/content/4/1/45
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SHARPs, complementary or not, are obvious candidates
for receptor agonist or antagonist functions. However,
there is an even more exciting and less expected therapeu-
tic application of complementary peptides. Some experi-
ments suggest that immunization with complementary
peptides to receptors induces production of ligand-like
antibodies, with ligand-like biological effects. Just imag-
ine the possibility of inducing insulin-like antibodies by
immunization with designed complementary peptides to
insulin-receptors and obtaining insulin-like effects (regu-
lation will of course be a problem to solve); or treating GH
deficiency by raising GH-like antibodies using GH-recep-
tor complementary peptides for immunization. This
seems like science fiction today, but Blalocks' experi-
ments, for example, are already pointing in that direction
[27].
Is protein therapy an alternative to gene therapy? Yes.
Gene therapy is technically still difficult to perform and
the effect is irreversible. The effects of protein therapy are
short-lived and reversible (if immunization does not
occur).
Software
SeqForm [78], SeqPlot [79], Dotlet, Mfold [64], SeqX
[57].
Patents
Blalock [101], Omichinski [102], Biro [103].
Abbreviations
amino acid complementarity: the physico-chemical com-
plementarity (size, charge, hydropathy) of amino acid
pairs as well as their origin from complementary codons
complementary amino acids: amino acid pairs, coded by
complementary codons
NA: nucleic acid
P: protein
PC: Proteomic Code, the comprehensive rules describing
the origin and nature of amino acid complementarity
SHARP: Specific High Affinity Reacting Peptides
W-C base pairs: Watson-Crick's complementary base
pairs.
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